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Abstract 
Introduction: Non-invasive brain stimulation techniques are being trialed to 
induce neuroplasticity for meaningful purposes. Transcranial direct current 
stimulation (tDCS) is one such brain stimulatory technique, which involves 
delivering low amplitude direct current (1-2mA) to the brain via scalp 
electrodes. A review of the literature has suggested that repeated daily tDCS 
could induce lasting effects in the motor domain in a healthy population and in 
both the sensory and motor domains in a clinical population (Boggio et al. 
2007, Mori et al. 2012, Reis et al. 2009). Of interest was whether increasing 
tDCS dose could evoke cumulative body sensory system function alteration in 
a healthy population.   
Aims: A systematic review aimed to review the literature most relevant to 
1_the effects of sensory cortex tDCS on sensory threshold related outcome 
measures and 2_the effects of motor cortex tDCS on pain threshold/intensity 
related outcome measures. Study 1 aimed to investigate the effects of 
consecutive daily sessions of tDCS on a sensory psychophysical outcome 
measure in a healthy population. Study 2 aimed to investigate the effects of 
consecutive daily sessions of tDCS on a series of pain related 
psychophysical, subjective and objective outcome measures in a healthy 
population as well as investigate the correlation between the baseline pain 
related psychophysical, subjective and objective outcome measures in a 
healthy population.  
Methods: A systematic review of the literature most relevant to the aims of 
studies 1 and 2 was firstly undertaken. Randomised controlled trial 
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methodology was then utilised in Study 1 to assess the effects of 5 
consecutive daily sessions of active (anodal) or sham sensory cortex tDCS on 
one psychophysical (i.e. vibration detection thresholds) measure in 29 healthy 
human volunteers. In Study 2, randomised controlled trial methodology was 
used to assess the effects of 5 consecutive daily sessions of active (anodal) 
or sham motor cortex tDCS on psychophysical (i.e. electrical, mechanical 
pressure and thermal detection and pain thresholds), subjective (i.e. electrical, 
thermal and mechanical pressure pain visual analogue scales (VAS)) and 
objective (i.e. salivary cortisol) outcome measures in 42 healthy human 
volunteers. Cross-sectional analysis of baseline data was also used in Study 
2 to explore bivariate correlations between examined outcome measures.  
Results: The review indicated both methodological limitations and 
heterogenous tDCS induced effects for trials. The review also revealed that 
repeated stimulation was one area that researchers had failed so far to focus 
on. Studies 1 and 2 demonstrated that consecutive daily sessions of anodal 
tDCS could not consistently alter psychophysical, subjective and objective 
outcome measures compared to sham in a healthy population. Study 2 also 
demonstrated statistically significant correlations between psychophysical and 
subjective outcome measures in a healthy population.  
Conclusion: The results of studies 1 and 2 suggest that increasing tDCS 
dose does not result in more consistent anodal tDCS induced effects on body 
sensory/pain perception in a healthy population.  As well, the results of Study 
2 also may provide further evidence of the clinical utility of different types of 
pain assessments. 
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Chapter 1  
Introduction & Literature review  
In line with the research goals of this thesis, this section will first briefly review 
the history, principle, key variables, key limitations and standard delivery 
parameters of a non-invasive nervous system stimulation technique, namely 
transcranial direct current stimulation (tDCS). This section will then briefly 
review clinical and research applications for tDCS in the sensory and motor 
domains. Finally, this section will look at postulated mechanisms for tDCS 
induced post stimulation effects. Further critical review of the relevant 
literature relating to the potential effects of tDCS on sensory/pain perception 
in a healthy human population is presented in a systematic review, which is 
presented in Chapter 2. 
 
1.1 The history of tDCS  
Transcranial application of weak direct currents to the human brain was 
initially performed in the 1960’s, trialed mainly on patients living with 
psychiatric disorders. These preliminary studies revealed that stimulation 
could improve either depressive or manic symptoms (Costain, Refearn & 
Lippold 1964, Carney 1969).  
Further research in the 1980’s revealed lasting tDCS induced effects on 
choice reaction time tasks in a healthy population (Jaeger et al. 1987). 
Despite this, interest with the device seemingly faded, which may have been 
the result of a lack of methods to monitor its effects beyond the 
phenemological level (Wassermann et al. 2008).  
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The ability to conveniently monitor induced changes to brain activity with 
techniques like transcranial magnetic stimulation (TMS) and functional 
magnetic resonance imaging (fMRI), however, has helped to validate the 
tDCS technique and seemingly spark renewed interest with the device 
(Nitsche, Paulus 2000). Currently, tDCS has been shown to affect a variety of 
functions in healthy humans and neuropsychiatric conditions (Flöel 2014, 
Shin, Foerster & Nitsche 2015).   
 
1.2 The principle of tDCS  
A constant direct current is delivered to the brain in tDCS, which is caused by 
asserting the two poles of an electric battery to the brain (Kropotov 2009). 
However, tDCS is not able to induce neuronal action potentials. This rests 
largely on the fact that the static uniform extra-cellular electric fields that are 
present in tDCS simply cannot yield the rapid depolarization required for this 
to occur (Nitsche et al. 2008). Instead, tDCS affects neuronal activity through 
alteration of the transmembrane potential of exposed brain parenchyma, 
causing either tonic depolarisation or hyper-polarisation of the tissue’s 
membrane (Creutzfeldt, Fromm & Kapp 1962, Purpura, McMurtry 1965).  This 
action consequently leads to an alteration of both the level of excitability and 
firing rate of the neurons affected. The direction of polarization is determined 
by the orientation of the individual neurons in the induced electric field 
(Ardolino et al. 2005).   
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1.3 Key tDCS variables, limitations and delivery 
parameters 
There are several key variables that influence both the level and direction of 
the tDCS induced response. These include current density, stimulation 
session duration/timing and electrode polarity/positioning.  
Current density determines the electrical field strength and is reliant on both 
the current strength and size of the electrodes (Nitsche et al. 2008). With 
respect to current strength, Nitsche and Paulus (2000) and Batsikadze et al. 
(2013) demonstrated that increasing motor cortex tDCS current intensity 
(whilst maintaining same electrode size) can result in prolonged, larger or 
reversed after effects on the level of motor pathway excitability in a healthy 
human population. These effects on motor pathway excitability can be elicited 
by simply measuring alterations to motor cortex TMS induced motor evoked 
potentials (MEP) amplitudes recorded both before and after tDCS (Nitsche, 
Paulus 2000). 
With respect to electrode size, Nitsche et al. (2007) demonstrated that 
reducing stimulation electrode size area (whilst maintaining stimulation 
intensity) focused motor cortex tDCS induced after effects on motor pathway 
excitability in a healthy population. Using a 35cm2 stimulation electrode size, 
so that the stimulation electrode area covered the motor cortex muscle 
representations for both the abductor digiti minimi and first dorsal 
interosseous muscles, tDCS induced similar excitability changes for the FDI 
and ADM representations. Reducing the stimulation electrode area to 3.5 cm2 
so that the stimulation electrode area only covered the motor cortex muscle 
representation for the ADM produced excitability changes for the ADM 
representation but not for the FDI.   
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Stimulation duration and timing are also key variables that can affect the tDCS 
induced response. Nitsche and Paulus (2000) demonstrated that increasing 
the length (current duration varied between 1 and 5 minutes) of 1mA motor 
cortex tDCS resulted in prolonged and larger tDCS after effects on the level of 
motor pathway excitability in a healthy population. Further, Monte-Silva et al. 
(2013) demonstrated that continuous application of 1mA motor cortex tDCS 
for 26 minutes resulted in motor pathway excitability enhancement whereas 
spaced stimulation of the same total duration (e.g. 2x13 min of tDCS with a 20 
min interval) resulted in an abolishment or reduction of motor pathway 
excitability in a healthy population. 
Current flow direction is another important variable that has been indicated to 
influence the tDCS induced response and depends mainly on the positions of 
the electrodes and their polarity.  In conventional tDCS, both a positive 
(anode) and negative (cathode) electrode are utilised. The tDCS mechanism 
involves the movement of charged ions within the tissue (i.e. positive ions are 
attracted to a skin surface cathode; negative ions are attracted to a skin 
surface anode) (Schabrun 2010). With respect to electrode positioning, 
Nitsche and Paulus (2000) demonstrated that a motor cortex+contralateral 
forehead electrode arrangement achieved motor pathway excitability changes 
whereas motor-cortical, pre+post motor-cortical or occipital+contralateral 
forehead electrode arrangements could not in a healthy population.  
With respect to electrode polarity, Nitsche and Paulus (2000) also 
demonstrated that cathodal motor cortex tDCS reduced motor pathway 
excitability whereas anodal motor cortex tDCS enhanced motor pathway 
excitability in a healthy population whilst maintaining stimulation duration and 
intensity.  
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It is also worth mentioning that there are limitations of the device. These 
include stimulation focality and stimulus intensity. Firstly, conventional tDCS 
does incorporate two electrodes (Nitsche et al. 2007). Hence, the current 
flows throughout the brain between the two electrodes potentially producing 
nerve polarization over a large area of the brain (Priori, Hallett & Rothwell 
2009).  
Alternative montages, such as the 4 x 1 high definition electrode montage, 
have and are still being explored. Borckardt et al. (2012) has shown, using 
magnetic resonance imaging (MRI) derived computational models, that high 
definition electrode montages produce a more restricted current flow with 
comparable efficacy to conventional tDCS.  
Another key tDCS limitation is stimulus intensity. TMS applied over the motor 
cortex of one hemisphere at an adequate intensity can elicit a motor response 
(i.e. twitch) in the targeted muscle on the contralateral side. This motor 
response therefore represents an active biological marker or phemenological 
indicator of stimulation success (Priori, Hallet & Rothwell, 2009). In contrast, 
there are no standard protocols/markers to assess effectiveness of tDCS 
strength (or dose) (Priori, Hallet & Rothwell, 2009). Unlike TMS, tDCS 
strength is therefore not individually adjusted. 
There also exist recommended delivery parameters, which relate to the length 
and current density of stimulation. Conventional tDCS has repeatedly been 
shown to be delivered safely in humans when applied with current strengths ≤ 
2mA, through electrodes ~25-35cm2 large for durations up to ~20 min per 
treatment session (Nitsche et al. 2003b, Iyer et al. 2005). 
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1.4 tDCS tolerability and safety aspects 
Tolerability refers to the presence of uncomfortable and unintended effects 
(Woods et al. 2016). Headaches, local pain, dizziness, nausea, fatigue, skin 
redness and a tingling, itching or mild burning sensation under the area of the 
electrodes are known side effects with the use of tDCS (Brunoni et al. 2011). 
A phosphene sensation, associated with switching ‘on’ and ‘off’ the 
stimulation, has also been reported.  
Safety aspects refer to damaging effects (Woods et al. 2016). Skin damage 
(i.e. burns) has previously been reported (Palm et al. 2008). tDCS induced 
structural brain damage is most unlikely and ruled out with certain protocols 
(Woods et al. 2016). tDCS induced structural brain damage in an in vivo rat 
model could only be achieved with a charge density 2 orders of magnitude 
higher than the charge density currently applied in humans (Liebetanz et al. 
2009). Transient cognitive/behavioural disturbances have also been reported 
(Iuculano, Kadosh 2013). 
There are procedures to help minimise side effects. For example, ramping 
(i.e. steadily changing) current intensity helps to reduce phosphene 
sensations. As well, preparing electrodes with saline solution and preventing 
direct contact between skin and electrodes helps to reduce skin irritation 
(Woods et al. 2016). Furthermore, adhering to safety guidelines and using 
thorough subject exclusion criteria further lower potential risks. 
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1.5 Clinical and research applications for tDCS   
tDCS can be used either to modulate the steady state of the cortex by 
increasing or decreasing nervous system pathway excitability or to prime the 
nervous system to improve its responsiveness to other interventions 
(Schabrun 2010). In line with thesis related research goals, however, this 
chapter will not focus on research where tDCS has been used to prime the 
nervous system. This section will review research related to clinical and 
research applications for tDCS in the motor and sensory domains. It must be 
noted that the intention of this section is to provide a brief overview of 
research related to clinical and research applications for tDCS without critical 
appraisal. Critical appraisal of research most relevant to the thesis related 
research goals is provided with the Systematic Review in Chapter 2.  
1.5.1 tDCS effects on the motor domain   
Investigations examining the effects of tDCS on the motor domain have been 
carried out on both healthy and non-healthy populations. The effects of tDCS 
on two main outcome measures, namely motor pathway excitability and 
behavior, will now be explored in further detail. In line with this thesis research 
related goals, the following section also aims to highlight the effects of 
repeated stimulation sessions on abovementioned outcome measures.  
1.5.1.1 tDCS induced changes to the excitability of the motor pathway in 
a healthy population 
Research has investigated the effects of a single session of tDCS on the 
excitability of the motor pathway. As previously mentioned, motor cortex tDCS 
has been shown to alter the level of excitability of the motor pathway in a 
polarity-dependent manner in a healthy population (Nitsche, Paulus 2000).  
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Successive tDCS may also be able to influence tDCS induced changes to the 
level of excitability of the motor pathway. Alonzo et al. (2012) demonstrated 
that consecutive daily sessions of anodal motor cortex tDCS induced greater 
increases in MEP amplitude compared to second daily sessions of anodal 
motor cortex tDCS over a five day period. Interestingly, research later 
demonstrated that consecutive daily sessions of anodal motor cortex at a 
constant intensity (i.e. 2mA) or a gradually increasing intensity (i.e. 1-2mA) 
was equally effective in increasing motor pathway excitability in a healthy 
population (Gálvez et al. 2013). Furthermore, Bastani and Jaberzadeh (2014) 
demonstrated that with-in session repeated tDCS (i.e. two or three 
applications of 10 minute tDCS with an interval of 25 minutes) was preferable 
for modifying motor pathway excitability in a healthy population compared to a 
single application of 10 minute tDCS. 
1.5.1.2 tDCS induced changes to behavioural measures of motor 
function 
Motor cortex tDCS has been shown to influence aspects of motor behavior 
such as activities of daily living and motor learning in a healthy population. 
Boggio et al. (2006) and Hummel et al. (2010) demonstrated that a single 
session of anodal motor cortex tDCS could significantly improve Jebsen-
Taylor Hand Function Test performance (i.e. time taken to perform activities of 
daily living with one hand) in both a young and older aged healthy human 
population but not after sham tDCS. 
Alternatively, tDCS has also been shown to influence motor training. Reis et 
al. (2009) demonstrated that repeated daily sessions of anodal motor cortex 
tDCS in combination with motor training led to significantly enhanced motor 
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learning (the motor learning measure related to movement time and error rate 
of a sequential visual isometric pinch task) compared to sham tDCS. Analyses 
suggested that tDCS induced motor learning enhancement was primarily the 
result of a positive between sessions effect (i.e. offline consolidation). 
Interestingly, Reis et al. (2015) later demonstrated that tDCS applied only 
after the training of the sequential visual isometric pinch task did not induce 
skill gain.  
Motor cortex tDCS has also been shown to influence motor function in 
different non-healthy populations such as Parkinson’s disease and stroke. 
Fregni et al. (2006a) showed that a single session of anodal motor cortex 
tDCS significantly improved Unified Parkinson’s Disease Rating Scale motor 
scores (motor score related to tremor, bradykinesia, rigidity, postural instability 
and gait) as well as simple reaction time scores (time taken to press a 
computer keyboard key using their index finger in response to computer 
presented stimuli) compared to sham tDCS in a Parkinson’s disease 
population.  
Alternatively, Fregni et al. (2005) demonstrated that a single session of 
cathodal tDCS delivered to the motor cortex of the affected hemisphere in 
stroke patients significantly improved Jebsen-Taylor Hand Function test 
performance but not with sham tDCS.  
tDCS session frequency may also be able to influence tDCS induced changes 
to motor function. Boggio et al. (2007) later revealed that consecutive daily 
sessions of cathodal tDCS delivered to the unaffected hemisphere induced a 
greater percentage change from baseline in Jebsen-Taylor Hand Function 
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test performance compared to the Fregni et al. (2005) study findings (i.e. 16.7 
% vs. 11.7 %). Hence, it can be seen that a number of papers have shed light 
relating to the potential clinical benefits of tDCS on motor function in different 
non-healthy populations.  
1.5.2 tDCS effects on the sensory domain   
Research examining the effects of tDCS on the sensory domain has also 
been carried out on both healthy and non-healthy populations. The effects of 
tDCS on the two main outcome measures of sensory pathway excitability and 
somatosensory perception will now be discussed in further detail. In line with 
research related goals, this section also aims to highlight the effects of 
successive tDCS on the aforementioned outcome measures. 
1.5.2.1 tDCS induced changes to the excitability of the sensory pathway 
in a healthy population 
Research has investigated the effects of a single session of tDCS on the 
excitability of the sensory pathway. A single session of either motor or 
sensory cortex tDCS has been shown to alter the level of excitability of the 
sensory pathway in a polarity-dependent manner (Dieckhöfer et al. 2006, 
Matsunaga et al. 2004). Changes to the level of sensory pathway excitability 
were probed by analysing peripheral nerve electrical stimulation induced 
somatosensory evoked potentials (SEP) recorded both before and after tDCS, 
with changes shown to outlast the stimulation period for up to one hour 
(Dieckhöfer et al. 2006). Alternatively, Sugawara et al. (2015) demonstrated 
that a single session of either motor and sensory cortex tDCS altered the level 
of excitability of the sensory pathway by measuring alterations to peripheral 
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nerve electrical stimulation induced somatosensory evoked magnetic fields 
(SEF) recorded both before and after tDCS.  
1.5.2.2 tDCS induced changes to measures of somatosensory 
perception  
Research has highlighted the ability of tDCS in altering somatosensory (i.e. 
discrimination/detection) and pain (i.e. detection/intensity) function in a 
healthy population. Psychophysical measures can give an indication of 
sensory and pain threshold changes while scales (i.e. numeric or visual 
analogue) can allow subjective rating of pain intensity. Rogalewski et al. 
(2004) showed that a single session of cathodal tDCS applied to the non-
dominant motor cortex reduced tactile frequency discrimination thresholds for 
the non-dominant finger. No changes to tactile acuity, however, were seen 
with anodal and sham tDCS. Additionally, Boggio et al. (2008) showed that a 
single session of anodal motor cortex tDCS significantly increased current 
pain detection thresholds over time but not with sham tDCS. Research has 
also demonstrated that a single session of anodal motor cortex tDCS 
significantly reduced certain heat pain intensity scores compared to sham 
tDCS and/or natural history group (Aslaksen, Vasylenko & Fagerlund 2014).  
Research has also investigated the potential clinical benefit of repeated 
sessions of tDCS on somatosensory processing abnormalities associated with 
disorders such as multiple sclerosis and persistent pain. Mori et al. (2012) 
demonstrated that 5 consecutive daily sessions of anodal somatosensory 
cortex tDCS improved spatial discrimination thresholds in multiple sclerosis 
patients as opposed to sham tDCS that showed no effect. Improvements 
lasted ~2 weeks post stimulation. Moreover, Fregni et al. (2006b) 
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demonstrated that 5 consecutive daily sessions of anodal motor cortex tDCS 
resulted in significantly greater pain improvement (i.e. pain measured using 
pain visual analogue score) compared to sham stimulation and stimulation of 
the pre-frontal cortex in patients with fibromyalgia.  
 
1.6 Proposed molecular mechanisms for tDCS 
induced post-stimulation effects in humans 
The mechanisms underpinning the after effects of tDCS are not completely 
understood. tDCS induced after-effects may involve alterations to the 
membrane potential, neurotransmitter (i.e. glutamate and gamma-amino-
butyric acid {GABA}) involved synaptic transmission, protein level expression 
and neuromodulator activation (Nitsche et al. 2003a, Nitsche et al. 2004). 
With respect to membrane potential changes, Nitsche et al. (2003a) showed 
that sodium and calcium channel blockers, namely carbamazepine and 
flunarazine, could effectively block motor cortex anodal tDCS induced post 
stimulus changes to MEP amplitudes. In line with a cathodal tDCS induced 
hyperpolarizing effect on the neuronal membrane, flunarazine and 
carbamazepine did not alter cathodal after effects.  
With respect to neurotransmitter involved synaptic transmitter receptor 
changes, Nitsche et al. (2003a) further demonstrated that antagonizing 
glutamate receptors with the use dextromethorphane could abolish both 
anodal and cathodal motor cortex post stimulus effects on MEPs. Moreover, 
another study showed that lorazepam, a GABA agonist, enhanced and 
prolonged anodal tDCS induced effects on MEP amplitudes (Nitsche et al. 
2004). Finally, Stagg et al. (2009) found that anodal motor cortex tDCS 
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significantly reduced magnetic resonance spectroscopy (MRS) detected 
GABA concentrations within the stimulated cortex, whilst cathodal motor 
cortex tDCS resulted in reduced MRS detected glutamate and GABA within 
the stimulated cortex.  
With respect to protein level expression changes, research suggests that 
tDCS induced after effects may also be brain-derived neurotrophic factor 
(BDNF) dependent. Fritsch et al. (2010) demonstrated that combined tDCS 
and low frequency repeated electrical stimulation produced long-term 
potentiation (LTP) in motor cortex mouse slices. tDCS induced LTP, however, 
was absent in BDNF and tropomyosin related kinase B (TrkB) mutant mice. 
Another study also demonstrated using a retrospective analysis that carriers 
of the BDNF vall66met polymorphism, known to partially affect activity-
dependent BDNF secretion, showed enhanced tDCS induced plasticity 
compared to Val66Val carriers (Antal et al. 2010).  
Additionally, certain dopamine, adrenergic, acetylcholine and serotonin agents 
have previously been shown to alter anodal and cathodal tDCS induced after 
effects (i.e. abolish, enhance/prolong or turn inhibition into facilitation) 
(Nitsche et al. 2006, Nitsche et al. 2009, Nitsche et al. 2004, Kuo et al. 2007).  
In summary, tDCS post stimulus effects may act via membrane, neuro-
transmitter related synaptic transmission modulation, neuromodulator and 
neurotrophic based mechanisms. Further research appears to be required 
before firm conclusions can be made regarding the mechanisms of tDCS post 
stimulus effects.  
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1.7 Proposed central mechanisms for motor cortex 
tDCS induced post-stimulation effects on pain related 
outcome measures in humans 
In line with the research goals of this thesis, it is worthwhile reviewing the 
proposed central and peripheral mechanisms for motor cortex tDCS induced 
post-stimulation effects on pain related outcome measures in humans. The 
proposed central mechanisms that will be discussed in further detail include 
influencing cortico-thalamic pathways, descending opioid-based anti-
nociception and central stress related circuitry.  
Firstly, motor cortex tDCS could alter pain related outcome measures by 
influencing descending cortico-thalamic pathways. Research has 
demonstrated using fMRI (i.e. seed functional coupling analysis) that motor 
cortex anodal tDCS could alter functional coupling between the ipsilateral 
motor cortex and thalamus in a healthy human population (Polanía, Paulus & 
Nitsche 2012). Lang et al. (2005) also demonstrated motor cortex tDCS 
induced changes to regional cerebral blood flow in the thalamus relative to 
sham tDCS in a healthy human population.  
Motor cortex tDCS could also alter pain related outcome measures by 
influencing descending opioid-based anti-nociception. DosSantos et al. (2014) 
revealed that a single session of active and sham motor cortex tDCS affected 
Mu Opioid Receptor (MOR) activation differently in a healthy human 
population. Although both active and sham tDCS induced similar MOR 
activation in the precuneus and peri-aqueductal grey matter, only active tDCS 
induced MOR activation in the pre-frontal cortex whereas only sham tDCS 
induced MOR activation in the thalamus. Interestingly, only active tDCS 
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induced significant improvements to heat and cold pain thresholds compared 
to baseline and not after sham tDCS.  
Finally, motor cortex tDCS could also alter pain related outcome measures by 
influencing stress related central nervous system circuitry. Cortisol is an end 
product of the hypothalamic-pituitary-adrenal (HPA) axis. Binkofski et al. 
(2011) demonstrated that a single session of anodal motor cortex tDCS could 
lower serum cortisol levels compared to sham tDCS in a healthy human 
population. The findings therefore suggest that motor cortex tDCS may be 
able to influence central stress related circuitry such as the hypothalamic-
pituitary-adrenal (HPA) axis.  
In summary, it is plausible to suggest that motor cortex tDCS analgesia in a 
healthy population could in part be attributable to influencing cortico-thalamic 
pathways, central opioid receptor activity or central stress related circuitry 
(Knotkova, Nitsche & Cruciani 2013).  
 
1.8 Proposed peripheral mechanisms for motor cortex 
tDCS induced post-stimulation effects on pain related 
outcome measures in humans 
The proposed peripheral mechanisms that will be discussed in further detail 
include influencing peripheral levels of nociceptive neuropeptides or stress 
related hormones.  
The literature suggests a relationship between neuropeptides and 
nociception. Sensory neuropeptide substance P is involved in nociception and 
pro-inflammatory functions (Hernanz et al. 1993, Okano, Kuraishi & Satoh 
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1998) while research has also shown that levels of peripheral (i.e. plasma) 
substance P are significantly higher in chronic pain patients compared to 
healthy controls (Jang et al. 2011).  
Research also suggests a relationship between stress related hormones and 
nociception. Cortisol is an end product of the hypothalamic-pituitary-adrenal 
(HPA) axis. Persistent pain states may result in abnormal HPA stimulation, 
which for a certain amount of time can result in exaggerated levels of serum 
cortisol (Tennant, Hermann 2002). Research has also shown that salivary 
concentrations of cortisol are significantly higher in chronic pain patients 
compared to healthy controls (Vachon-Presseau et al. 2013). 
Hence, it could be postulated that tDCS induced effects on nociception could 
be associated with changes in the level of nociceptive peripheral 
neuropeptides such as substance P or stress related hormones such as 
cortisol. 
 17 
Chapter 2  
Systematic Review 
 
2.1 Introduction / Aim 
Reviews of the literature revealed that there are some investigations that have 
demonstrated that repeated daily sessions of tDCS could induce lasting 
effects in the motor domain in a healthy population and both the sensory and 
motor domains in a clinical population (Boggio et al. 2007, Mori et al. 2012, 
Reis et al. 2009). Of interest is whether increasing stimulation session 
frequency can evoke cumulative and lasting body sensory system function 
alteration in a healthy population. The aim of this review was to perform a 
systematic evaluation of the literature on research specific to the application 
of tDCS to a healthy human population in two distinct domains: 
1) the effects of sensory cortex tDCS on sensory threshold related outcome 
measures  
2) the effects of motor cortex tDCS on pain threshold and pain intensity 
related outcome measures. 
 
2.2 Methods 
2.2.1 Systematic review design 
The PRISMA guidelines for systematic review reporting were utilised as 
guidelines for conducting this systematic review (Moher et al. 2009). 
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2.2.2 Search strategy 
A search of 10 electronic databases including PubMed, CINAHL, EMBASE, 
PEDro, Informit Health Collection, Ovid Medline, Scopus, ACP Journal Club, 
The Cochrane Library, and PsychINFO was conducted in Jan 2015 to locate 
potential articles. The search terms included: transcranial direct current 
stimulation, Transcranial Direct Current Stimulation, tDCS, pain, analgesia, 
healthy, qst, sensor*, percept*, psychophysic* and sensation. The search 
strategy included the Boolean operators ‘and’ and ‘or’ in order to combine the 
search terms (refer to Table 1). The reference lists of the included studies 
were additionally searched to ensure all relevant articles would be identified.  
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2.2.3 Eligibility criteria 
2.2.3.1 Rationale for inclusion/exclusion criteria  
Search specific inclusion/exclusion criteria were used to produce 2 results, so 
that the two distinct aforementioned domains of the literature were reviewed 
(refer to Table 2). The first set of search results (Review A) includes literature 
that has investigated the effects of sensory cortex tDCS on sensory threshold 
related outcome measures in a healthy human population. The second set of 
results (Review B) includes literature that has investigated the effects of motor 
cortex tDCS on pain threshold and pain intensity related outcome measures in 
a healthy human population. 
2.2.3.2 Screening and selection procedures 
Initial screening of titles and abstracts in line with study specific inclusion and 
exclusion criteria took place to isolate potential relevant articles. Screening of 
extracted full text papers in line with study specific inclusion and exclusion 
criteria was then performed for final study eligibility and then divided into 
Review A and Review B (refer to Figure 1). The primary investigator screened 
all titles, abstracts, and full text papers prior to making a decision about study 
eligibility.  
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2.2.3.3 Data extraction procedures 
The data extracted from the studies relevant to the aims of this overall review 
were separated into 1) Methods (i.e. study design, sample size, body 
stimulation method, related outcome measure, Table 4) and delivery of 
intervention (i.e. tDCS type, stimulating electrode size, current intensity, 
current density, stimulation duration, Table 5) and 2) Results (i.e. sensory and 
pain outcome measure changes, Tables 6 and 7). Data was also extracted 
from two recent related systematic reviews to allow comparison (Vaseghi, 
Zoghi & Jaberzadeh 2014, Vaseghi, Zoghi & Jaberzadeh 2015b).  
2.2.4 Methodological quality assessment 
The modified Downs and Black 27 item checklist was used to evaluate the 
quality of included studies in this review (Table 3) (Downs, Black 1998). The 
areas the checklist assesses include: study reporting; external validity; 
internal validity; bias/confounding, and statistical power (Downs, Black 1998). 
The checklist has been evaluated as a suitable quality assessment tool for 
randomised and non-randomised intervention studies (Saunders et al. 2003). 
Two reviewers independently scored all papers.  If there was a disagreement, 
consensus was gained by discussion. As in previous studies, the tool was 
modified for use in this review (i.e. the question concerning statistical power 
was scored 1 if a power or sample size calculation was present and 0 if no 
power or sample size calculation was present) (Chudyk et al. 2009). 
Therefore, the total score was out of 28. The Downs and Black scores can be 
separated into 4 quality categories: excellent (26 to 28), good (20 to 25), fair 
(15 to 19), and poor (≤14) (Hooper et al. 2008).  
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2.2.5 Quantifying tDCS induced changes 
The percentage change from baseline value was obtained using exact 
percentage change from baseline values, exact mean values or graphed 
mean values (i.e. estimated; indicated by a ~) provided for at least one 
relevant outcome measure. A percentage change from baseline value 
assessment has previously been performed in a recent systematic review 
(Vaseghi, Zoghi & Jaberzadeh 2014). The obtained percentage change from 
baseline values for sensory, pain and pain intensity related outcome 
measures are outlined in Tables 6 and 7. Two included studies were excluded 
from this analysis because the percentage change from baseline value for any 
relevant outcome measure could not be calculated. No attempt was made to 
pool data, as the reviewers deemed combining the diverse outcome 
measures reported nonsensical.  
2.2.6 Analysis of results 
After establishing study eligibility, the single student investigator then used a 
critical narrative synthesis approach in order to critique, compare and contrast 
the results from the included studies.  
 
2.3. Results 
2.3.1 Search Strategy 
Figure 1 presents a PRISMA flow diagram.  Electronic database and 
reference list searches yielded 1375 potential articles. After abstract and title 
    24 
review and removal of duplicates, 16 articles were retrieved in full text. After 
full text review, 14 articles met the inclusion criteria. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Database search n = 666 
PubMed n= 119 
Embase n=199 
Scopus  n =135 
Ovid Medline n =97 
CINAHL n=14 
PscyhInfo n=75 
Cochrane Library n=27 
PEDro n=0 
Informit Health Collection n=0 
ACP Journal Club n=0 
Manual reference list n =709 
Id
en
tif
ica
tio
n 
Sc
re
en
in
g 
El
ig
ib
ili
ty
 
In
clu
de
d 
Potentially Relevant Articles 
n = 102 
Articles retrieved in full text 
and assessed for eligibility 
n = 16 
Articles included in review for 
Review A based on Study 1 
inclusion/exclusion criteria 
n = 3 
Articles included in review for 
Review B based on Study 2 
inclusion/exclusion criteria 
n = 11 
Articles excluded 
based on 
Title/Abstract and 
Duplication 
n = 1273 
Articles excluded 
based on duplication 
n = 86 
Articles not eligible 
based on not meeting 
either study criteria 
n = 2 
Figure 1 Prisma flow diagram for systematic review 
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2.3.2 Methodological quality assessment  
Table 3 demonstrates the Downs and Black scores and quality category for 
included studies. The range of scores within Review A was 22-24. All 3 
articles were of a good quality of evidence. While the range of scores was 18-
23 for Review B with 2 articles fair in quality of evidence and 9 articles good in 
quality of evidence. Most studies did not provide a comprehensive attempt to 
measure potential important adverse effects (item 8), the source population 
for participants (Item 11), the research setting (Item 13) and sample size 
power calculations (item 27). 
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2.3.3 Methodological parameters 
2.3.3.1 Study design  
Study design characteristics for Review A and B are outlined in Table 4. The 3 
studies in Review A were all crossover designed while 10 of the 11 studies in 
Review B were crossover designed. The remaining 1 study was a parallel 
design.  
2.3.3.2 Participant numbers 
Participant number characteristics for included studies are outlined in Table 4. 
The total number of participants across the studies in Review A was 31 with 
the number of participants ranging from 9 to 12. The total number of 
participants across the studies was 225 in Review B with the number of 
participants ranging from 8 to 75.  
2.3.3.3 Outcome measures 
Thesis related outcome measure and body stimuli types found in included 
studies are outlined in Table 4. The outcome measure types used by studies 
in Review A and B included sensory and pain thresholds as well as pain 
intensity scores. Body stimuli type included thermal and mechanical for 
studies in review A. The list of body stimuli type found in studies in review B 
included electrical, thermal, mechanical and laser.  
2.3.3.4 tDCS interventions  
tDCS intervention characteristics for included studies are outlined in Table 5. 
The stimulating electrode size, stimulation intensity, current density and 
stimulation duration / stimulation session across the studies in Review A was 
25 to 35 cm2, 1mA, 0.029 to 0.04 mA / cm2 and 15 to 20 minutes respectively. 
The stimulating electrode size, stimulation intensity, current density and 
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stimulation duration / stimulation session across the studies in Review B was 
16 to 35 cm2, 1 to 2 mA, 0.029 to 0.063 mA / cm2 and 5 to 40 minutes 
respectively. The type of direct current stimulation found in studies for both 
Review A and B included anodal and cathodal. 
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Presentation of certain results (i.e. relating to quantifying tDCS induced 
change) and relevant discussion (i.e. relating to methodological quality, tDCS 
methods and quantifying tDCS induced change) for reviews A and B has been 
separated for ease of reading.  
2.3.4 Quantifying tDCS induced changes – Review A 
Percentage change from baseline values found in included studies are 
outlined in Table 6. The range of percentage changes from baseline for 
sensory thresholds following anodal, cathodal and sham tDCS respectively is 
listed below: 
x Sensory thresholds:  
o Anodal; -29.3 to +0.8  
o Cathodal: +1.7 to +2.5   
o Sham; -0.3 to +1.6 
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2.3.5 Discussion – Main findings for Review A 
Following our systematic literature review 3 studies, meeting inclusion criteria, 
were identified to provide a summary of the literature that has investigated the 
effects of sensory cortex transcranial direct current stimulation on body 
sensory threshold related outcome measures in a healthy population. 
With respect to methodological quality, overall the 3 studies demonstrated a 
good-quality mean method score of 22.66/28 with scores ranging from 22-24 
(refer to Table 3).  
Of interest, most studies lacked information relating to potential adverse 
effects (item 8), participant source (item 11), research setting (item 13) and 
statistical power reporting (item 27).  
When cross-referencing the scored studies for two recent and our systematic 
review only one paper (Grundmann et al. 2011) was evaluated using the 
Downs and Black scoring method. This occurred as it appears that neither 
Antal et al. (2008) nor Rogalewski et al. (2004) were included in our 
systematic review due to a variation in specific inclusion and exclusion 
criteria. Furthermore, Vaseghi, Zoghi & Jaberzadeh (2014) only included 
studies published up to July 2012.  
Of particular note was that the methodological scoring carried out in this 
review for Grundmann et al. (2011) was 6 points higher compared to scoring 
reported in two similar recent systematic reviews (Vaseghi, Zoghi & 
Jaberzadeh 2014, Vaseghi, Zoghi & Jaberzadeh 2015b). 
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It is difficult to exactly establish the reason for this difference as the two 
previous systematic reviews do not provide a breakdown of the Downs and 
Black thus not allowing a scoring comparison to be carried out.  
Our higher Downs and Black checklist score could be attributed to differences 
in how items related to study design and participant flow information were 
interpreted and scored. Of note were that all included studies for review A 
were a crossover designed. As a result, the scorers automatically scored 
items 21, 23 and 25 a 1 and item 5 a score of 2. Further, although studies did 
not present detailed participant flow information (e.g. numbers of participants 
enrolled versus analysed), the scorers automatically scored items 9, 19 and 
26 a score of 1 if participant numbers appeared to be constant throughout the 
entire manuscript.  
With respect to methods, the sensory cortex tDCS variables used were fairly 
consistent (refer to Table 5). It is also worthy to note that none of the included 
studies investigated the use of repeated daily tDCS. Secondly, the sample 
sizes were small (refer to Table 4), which is in line with a lack of sample size 
power calculation information. Finally, the study designs were relatively 
consistent and all studies appeared to use mechanical modality sensory 
thresholds. 
With respect to quantifying tDCS induced change, percentage change from 
baseline sensory threshold values following anodal, cathodal or sham sensory 
cortex tDCS overall ranged from -29.3 to +2.5 (refer to Table 6). However, 
9/10 values were ≤ 10 %.  
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When cross-referencing the studies that had a percentage change from 
baseline score reported for the two recent and one present systematic review, 
it appeared that only Grundmann et al. (2011) were scored by all three 
systematic reviews. As well, only Vaseghi, Zoghi and Jaberzadeh (2014) and 
the present systematic review provide a percentage change from baseline 
score for Ragert et al. (2008). 
With respect to percentage change from baseline findings calculated for 
Grundmann et al. (2011) and Ragert et al. (2008) these were higher than 
those reported by our systematic review.  
Data extraction differences may help to explain this. Firstly, Grundmann et al. 
(2011) report tDCS induce changes to cold detection thresholds as the 
difference detected against a baseline temperature of 32 degrees celsius. 
Hence, a mean value change from -1.2 degrees celsius to -2.1 degrees 
celsius (difference from baseline; 32 degree celsius) would correspond to ~ 
75% change from baseline. In contrast, using the current systematic review 
methodology, a mean value change from 30.8 degrees celsius to 20.9 
degrees celsius would correspond to ~3% change from baseline. In addition, 
the present systematic review did not contact authors for means of desired 
outcome measures when means were not presented numerically or 
accessible from figures and graphs. As a result, the review did also not report 
the Grundmann et al. (2011) heat, mechanical and vibration sensory threshold 
percentage change from baseline scores.  
The slight variability present in percentage change from baseline values may 
be due to outcome measure type. Greater percentage change from baseline 
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values were reported for effects of anodal sensory cortex tDCS on mechanical 
sensory discrimination thresholds compared to thermal sensory detection 
thresholds (refer to Table 6).  
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2.3.6 Quantifying tDCS induced changes – Review B 
Percentage change from baseline values found in the included studies are 
outlined in Table 7. The range of percentage changes from baseline for each 
outcome measure type following anodal, cathodal and sham tDCS 
respectively is listed below: 
x Sensory thresholds:  
o Anodal; -10 to +10.7  
o Cathodal: -3.4 to +96.2   
o Sham; -0.3 to +9.7 
 
x Pain thresholds:  
o Anodal; -2.9 to +85  
o Cathodal: 0.2 to +5.9   
o Sham; -0.8 to +75 
 
 
x Pain intensity:  
o Anodal; -40.9 to +16.2  
o Cathodal: -2.2 to +5.88   
o Sham; -37.5 to +31 
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2.3.7 Discussion – Main findings for Review B  
Eleven studies that met the inclusion criteria were identified to evaluate the 
literature that has investigated the effects of motor cortex transcranial direct 
current stimulation on pain threshold and pain intensity related outcome 
measures in a healthy population.  
With respect to methodological quality, overall the 11 papers demonstrated a 
good-quality mean method score of 20.64/28 with scores ranging from 18-23 
(refer to Table 3).  
Of interest, most studies lacked information relating to potential adverse 
effects (item 8), participant source (item 11), research setting (item 13) and 
statistical power reporting (item 27). As well, only roughly half of the studies 
performed double blinding (items 15 and 24). Interestingly, only 2 papers 
measured effectiveness of blinding with sham tDCS (Ihle et al. 2014, Reidler 
et al. 2012).  
Studies that were scored by our present systematic review and at least 1 of 
the systematic reviews published by Vaseghi, Zoghi and Jaberzadeh in 2014 
and 2015 include only Csifisak et al. (2009), Hansen et al. (2011) and Boggio 
et al. (2008).  
There are reasons for differences in the variance of the studies included or 
not included in the three different reviews. Firstly, the present systematic 
review did not include Terney et al. (2008) due to review specific inclusion and 
exclusion criteria. As well, only studies published to July 2012 were included 
in Vaseghi, Zoghi and Jaberzadeh (2014). 
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The methodological scoring carried out in this review was 2-6 points higher 
compared to scoring reported in the two past systematic reviews.      
Reasoning for methodological quality scoring differences is outlined in the 
discussion for Review A. 
With respect to methods, relatively similar tDCS variables were used (refer to 
Table 5). Interestingly, repeated daily tDCS was not used in any included 
studies. Secondly, included studies generally had relatively small sample 
sizes (refer to Table 4). Additionally, the study designs were fairly similar. 
Finally, most studies used thermal modality sensory thresholds. 
With respect to quantifying tDCS induced change, the results will be 
discussed in relation to 3 distinct areas of sensory thresholds, pain thresholds 
and pain intensity. 
Firstly, percentage change from baseline sensory threshold values following 
anodal, cathodal or sham motor cortex tDCS ranged from -10 to +96.2 (refer 
to Table 7). However, 14/17 values were ≤ 10%. 
Studies that were percentage change from baseline sensory threshold scored 
by our present systematic review and at least 1 of the systematic reviews 
published by Vaseghi, Zoghi and Jaberzadeh in 2014 and 2015 include only 
Csifisak et al. (2009), Bachmann et al. (2010) and Boggio et al. (2008).  
Of note, the percentage change from baseline scores for sensory thresholds 
calculated for Csifisak et al. (2009), Bachmann et al. (2010) and Boggio et al. 
(2008) in the present systematic review were generally smaller to those 
reported in the 2 recent systematic reviews (Vaseghi, Zoghi & Jaberzadeh 
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2014, Vaseghi, Zoghi & Jaberzadeh 2015b). Refer to the discussion for 
review A for reasoning for percentage change scoring differences. 
The variability in motor cortex induced sensory threshold percentage change 
from baseline values may be due to outcome measure type. For example, the 
biggest percentage change from baseline values in this review was reported 
for effects of cathodal tDCS on mechanical (i.e. Von Frey) sensory thresholds 
(i.e. + 96.2). In contrast, percentage change from baseline values in this 
review for effects of tDCS on thermal (i.e. cold), electric and laser pain 
thresholds measure were all less than 10 percent. 
Secondly, percentage change from baseline pain threshold values following 
anodal, cathodal or sham motor cortex tDCS ranged from -2.9 to +85 (refer to 
Table 7). However, 14/18 values were ≤ 10%. 
Studies that were percentage change from baseline pain threshold scored by 
our present systematic review and at least 1 of the systematic reviews 
published by Vaseghi, Zoghi and Jaberzadeh in 2014 and 2015 include only 
Csifisak et al. (2009) and Boggio et al. (2008).  
Of note, the percentage change from baseline scores for pain thresholds in 
the present systematic review for Csifisak et al. (2009) and Boggio et al. 
(2008) were typically smaller than those reported in recent systematic 
reviews.  
One reason for this may be due to possible incorrect data extraction. For 
example, Boggio et al. (2008) specifically provide percentage change from 
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baseline values that do not line up with those reported in Vaseghi, Zoghi and 
Jaberzadeh (2014).  
The variability in motor cortex induced pain threshold percentage change from 
baseline values may be due to outcome measure type. For example, the 
biggest percentage change from baseline values in this review was reported 
for effects of tDCS on face thermal (i.e. cold) pain thresholds (i.e. +85). In 
contrast, percentage change from baseline values in this review for effects of 
tDCS on thermal (i.e. heat), electric and laser pain thresholds measure were 
all less than 10 percent. 
Thirdly, percentage change from baseline values following anodal, cathodal or 
sham motor cortex tDCS for pain intensity scores ranged from -40.9 to +31 
(refer to Table 7).  
Interestingly, both the recent Vaseghi systematic reviews did not extract 
percentage change from baseline scores for pain intensity related outcome 
measures in a healthy population (Vaseghi, Zoghi & Jaberzadeh 2014, 
Vaseghi, Zoghi & Jaberzadeh 2015b).  
It is also important to note that motor cortex tDCS induced pain intensity 
percentage change from baseline values may be affected by outcome 
measure type and body location. For example, bigger percentage change 
from baseline values in this review were reported for effects of anodal tDCS 
on forearm thermal pain intensity scores compared to effects of tDCS on 
finger/head electrical pain intensity scores.  
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2.3.8 What’s new 
Compared to the two previous systematic reviews published by Vaseghi, 
Zoghi and Jaberzadeh in 2014 and 2015, our systematic review involved the 
inclusion of 6 new trials.  
Methodological differences (i.e. differences in quality scoring, data extraction 
and included studies) have presumably led to altered conclusions regarding 
methodological quality and tDCS induced change.  
With respect to methodological quality, the analysis suggests that overall 
methodological quality was good.  
With respect to quantifying active tDCS induced changes compared to 
baseline, the analysis suggests that overall percentage changes from 
baseline were variable but mostly minimal (i.e. ≤ 10 %).  
Finally, our current systematic review quantified tDCS induced changes on 
pain intensity compared to baseline in a healthy population. tDCS induced 
changes on pain intensity were generally slightly greater compared to tDCS 
induced changes on sensory and pain thresholds.  
2.3.9 Strengths and limitations of the review  
The review is subject to certain limitations. To begin with, some of the mean 
values obtained for quantifying tDCS induced changes had to be retrieved 
from graphs from the papers. This methodology may therefore have 
introduced data inaccuracy. The review was also limited to English-language 
articles.  
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2.3.10 Conclusions and research implications 
In summary, there have been numerous investigations into the effects of 
sensory and motor cortex transcranial direct current stimulation on body 
sensory and pain related outcome measures in a healthy population. Critical 
appraisal of this literature revealed key methodological quality limitations, 
which have impaired the quality of evidence. Critical appraisal of the literature 
also revealed that single session anodal, cathodal and sham motor and 
sensory cortex tDCS induced inconsistent but mostly minimal percentage 
change from baseline values for body sensory and pain related outcome 
measures. Future efforts may therefore benefit by increasing stimulation 
frequency (e.g. using repeated daily tDCS), which might help to establish 
more consistent effects on physical sensory/pain thresholds (i.e. detection/ 
tolerance) and pain intensity in a healthy population.        
The following section provides the framework for a comprehensive project 
investigating the effects of repeated sessions of tDCS on somatosensory 
function in a healthy population and the validity for assessing pain with 
physical quantitative sensory measures (psychophysical devices) compared 
to the subjective pain measures (i.e. Visual Analogue Scale (VAS); self-
reported general pain sensitivity questionnaire (SRGPSQ)) and objective pain 
related salivary biomarkers. 
 
2.4 Study design rational and significance  
Numerous studies have investigated the effects of transcranial direct current 
stimulation (tDCS) on measures of somatosensory perception in a healthy 
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population. However, systematic reviews indicate both methodological 
limitations and heterogenous tDCS induced effects for existing trials. The 
reviews also reveal that stimulation frequency (e.g. using repeated daily 
tDCS) is one area that researchers have failed so far to focus their attempts 
on.  
The objective of the first study (that follows) was therefore to investigate the 
effects of repeated daily sessions of tDCS on psychophysical measures of 
somatosensory function only by measuring the effects of repeated daily tDCS 
on vibration detection thresholds in a healthy human population.  
The second study had three distinct objectives. The primary objective was to 
investigate the effects of repeated daily sessions of tDCS on psychophysical 
and subjective measures of somatosensory function (i.e. detection and 
perception) by measuring the effects of repeated daily tDCS on 
psychophysical thresholds (i.e. electric, thermal and mechanical pressure 
detection and pain thresholds) and subjective pain scores (i.e. electric, 
thermal and mechanical pain visual analogue scales) in a healthy human 
population.  
The second objective was to investigate the effects of repeated daily sessions 
of tDCS on objective pain related biological markers by measuring the effects 
of repeated sessions of tDCS on salivary cortisol and substance P levels post 
experimental pain stimulation in a healthy human population.  
The third and final objective of the second study was to investigate the 
associations and/or differences between different psychophysical thresholds 
(i.e. electrical, mechanical and thermal detection and pain thresholds), 
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subjective pain measures (i.e. electrical, mechanical and thermal visual 
analogue scales (VAS); self-reported general pain sensitivity questionnaire 
(SRGPSQ)) and objective pain related biomarkers (i.e. salivary substance P 
and cortisol levels) in a healthy human population.  
Measuring tDCS induced effects on psychophysical, subjective and objective 
outcome measures in a healthy population would be important to 1) better 
understand how tDCS may lead to changes in somatosensory processing, 2) 
provide a rationale for potential therapeutic use of tDCS in the treatment of 
nervous system disorders such as in pain conditions and stroke and 3) help 
discover how to best apply tDCS in the treatment of nervous system disorders 
such as in pain conditions and stroke. 
Measuring associations between the different abovementioned measures 
would be important to firstly potentially provide further evidence of their clinical 
utility and secondly provide further evidence of how to best utilise the 
measures in a clinical setting. 
 
2.5 Aims  
The aims include: 
1) To investigate the effects of five consecutive daily sessions (1 session / 
treatment day) of anodal sensory cortex tDCS on VDT for vibrations (i.e. 
vibration frequency either 30 or 200Hz) delivered to the distal pad of both third 
digits in a healthy population.  
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2) To investigate the effects of five consecutive daily sessions (1 session / 
treatment day) of anodal motor cortex tDCS in a healthy human population 
on: 
a)_psychophysical thresholds (i.e. electrical, thermal and mechanical 
detection and pain thresholds),  
b)_subjective pain intensity scores (i.e. electrical, thermal and mechanical 
pain visual analogue scales (VAS), 
c)_objective salivary biomarkers (i.e., substance P and cortisol) levels  
 
2.6 Hypotheses  
This thesis’s hypotheses include: 
1_Five consecutive daily sessions (1 session / treatment day) of anodal 
sensory cortex tDCS results in significantly lowered vibration detection 
thresholds (VDT) for vibrations (i.e. 30 or 200Hz) delivered to the distal pad of 
both third digits compared to the effects of sham sensory cortex tDCS in a 
healthy human population. 
 
2_Five consecutive daily sessions (1 session / treatment day) of anodal motor 
cortex tDCS results in significantly 
a_lower electrical detection thresholds, higher electrical, thermal and 
mechanical pain thresholds and lowered subjective pain scores (i.e. electrical, 
thermal and mechanical pain visual analogue scales) compared to the effects 
of sham motor cortex tDCS in a healthy human population. 
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b_lower levels of cortisol and substance P after experimental pain stimulation 
compared to the effects of sham motor cortex tDCS in a healthy human 
population. 
3_Are there correlations between different psychophysical thresholds (i.e. 
electrical, thermal and mechanical detection and pain thresholds), subjective 
pain measures (i.e. electrical, thermal and mechanical pain visual analogue 
scales (VAS); self-reported general pain sensitivity questionnaire (SRGPSQ)) 
and objective pain related biomarkers (i.e. salivary substance P and cortisol 
levels) in a healthy human population. 
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Chapter 3  
Study 1 and Study 2 
 
3.0 Study 1 
Modulation of sensory cortex function with transcranial direct current 
stimulation 
Brookes Folmlia, Bulent Turmana, Peter Johnsona, Wayne Hinga, Allan 
Abbotta,b,c 
aFaculty of Health Science and Medicine, Bond University, Australia. 
bDivision of Physiotherapy, Department of Neurobiology, Care Sciences and 
Society, Karolinska Institutet, Stockholm, Sweden. 
cDepartment of Physiotherapy, Karolinska University Hospital, Stockholm, 
Sweden. 
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3.1 Abstract 
Background: Research has investigated single session tDCS induced effects 
on body sensory detection thresholds. Systematic reviews indicate 
heterogenous treatment effects for such trials. Increasing tDCS dose may 
form more consistent tDCS induced effects on sensory detection thresholds.  
Objective/Hypothesis: The study’s objective was to investigate the effects of 
five consecutive daily sessions (1 session / treatment day) of sensory cortex 
tDCS on vibration detection thresholds (VDT) of the upper limbs in a healthy 
human population. It was therefore hypothesised that the use of tDCS would 
effectively modulate VDT for vibrations delivered at two frequencies (30Hz 
and 200Hz) to both upper limbs over time.  
Methods: Randomised controlled trial methodology was used to assess VDT 
before and after five consecutive daily sessions of either active (anodal) or 
sham tDCS applied to the dominant somatosensory cortex in 29 healthy 
volunteers (mean age +/- SD = 22.86 +/- 6.78; 15 males and 14 females) 
using a method of limits protocol. Possible within-subjects (i.e. factor = time) 
and between-subjects (i.e. factor = treatment) statistical differences were 
examined using the mixed model analysis of variance (ANOVA). 
Results: A mixed model ANOVA demonstrated no significant differences due 
to treatment alone. 
Conclusion: Increasing tDCS dose not increase the consistency/efficacy of 
tDCS induced effects on vibro-tactile sensitivity in a healthy human 
population. 
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3.2 Introduction 
Research is exploring the use of non-invasive brain stimulation techniques to 
induce neuroplasticity for meaningful purposes. tDCS is one such brain 
stimulatory technique, which involves delivering low amplitude direct current 
(1-2mA) to the brain via scalp electrodes (Nitsche et al. 2008).  
tDCS has previously been shown to alter the excitability of sensory and motor 
pathways as well as having lasting effects on behavioural aspects of nervous 
system function in a healthy human population (Rogalewski et al. 2004, 
Nitsche, Paulus 2001). A systematic review identified that few studies have 
investigated the effects of sensory cortex tDCS on sensory detection 
thresholds in a healthy human population (see Chapter 2). The studies were 
of good methodological quality but the single session tDCS induced 
percentage change from baseline values were mostly minimal and 
inconsistent (Grundmann et al. 2011, Ragert et al. 2008).  
There is some research that suggests that repeated daily tDCS may have 
cumulative effects on neuroplasticity induction (i.e. changes to motor pathway 
excitability and behavior) in a healthy population (Alonzo et al. 2012, Reis et 
al. 2009). It therefore may be that repeated sensory cortex tDCS sessions are 
required to yield larger and more consistent effects on sensory thresholds in a 
healthy population. 
The vibration detection threshold (VDT) measure is an objective method of 
testing human sensory function in research procedures (Stuart et al. 2003). 
The aims of this research study were two fold:  
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1_to establish the effects of five consecutive daily sessions (1 session / 
treatment day) of sensory cortex tDCS on VDT in a healthy human population 
compared to sham tDCS.  
2_to establish whether time influences tDCS induced effects on VDT.  
Previous research has demonstrated that anodal tDCS can increase the level 
of excitability of both the human motor and sensory pathways (Matsunaga et 
al. 2004, Nitsche, Paulus 2000, Sugawara et al. 2015). It was therefore 
hypothesised that consecutive daily sessions of anodal sensory cortex tDCS 
would effectively lower VDT compared to sham over time. Investigating tDCS 
induced effects on VDT in a healthy human population would provide further 
evidence for the effectiveness of tDCS as a tool to manipulate cortical 
plasticity, which could translate into advanced treatment for populations 
characterised by sensory cortex function abnormalities. 
 
3.3 Material and methods 
3.3.1 Study design 
A prospective randomised single blinded controlled trial was instituted 
involving one experimental and one sham control group.  
With respect to randomisation, subjects were allocated to their respective 
groups through random concealed allocation. The randomisation procedure 
involved concealed drawing pieces of paper, which had a noted intervention 
(i.e. active or sham).  
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With respect to blinding, participants were not told what intervention group 
they belonged to. The same investigator administered the brain stimulation 
and recorded the VDT. The investigator could not be blinded due to limitations 
in resources to finance equipment or additional personnel to enable blinding 
of the investigator. 
3.3.2 Setting 
The following research was carried out in a quiet, controlled and appropriate 
University research laboratory.  
3.3.3 Sample size power calculation 
An a priori sample size power analysis was used to calculate required sample 
size to test ANOVA within-subjects factor (6x time points) and between-
subjects factor (2x treatment group) interactions. Using G*Power software, 
eta-squared can be used to calculate effect size (f) for ANOVA (Prajapati, 
Dunne & Armstrong 2010). Aslaksen, Vasylenko and Fagerlund (2014) 
previously reported eta-squared values in the range of .07 to .33 for significant 
tDCS induced effects on experimental pain in a healthy human population. 
Considering 95% statistical power, a two sided α =.05 and a ‘moderate’ effect 
size = 0.27 a total of n=24 were required (Faul et al. 2007, Cohen 1992).  
3.3.4 Participants 
Twenty nine subjects were allocated to an experiment group and a control 
group consisting of 14 and 15 subjects respectively. Table 8 reveals 
participant flow information. The subjects in the experimental group received 
anodal sensory cortex tDCS. Subjects were recruited from the staff and 
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student population at Bond University, Australia. Table 9 reveals participant 
demographic information. Participants were given written and oral information 
regarding the investigation (see Appendix 1). Persons were excluded from 
participation if they: had any metallic or magnetic pieces inside the brain/skull 
(except titanium); had any implanted metal devices; had epilepsy or have ever 
experienced a convulsion or seizure; had any first degree relatives with 
epilepsy; had any hearing problems or tinnitus; consume heavy amounts of 
alcohol (e.g. +4 standard drinks/day) very regularly; had any recent or severe 
heart disease or were possibly pregnant (see Appendix 2). The participants 
were recruited between July 2012 and May 2013. Participation was voluntary 
and all subjects provided written informed consent prior to inclusion into the 
study (see Appendix 3). The study was approved by the Bond University 
Human Research Ethics Committee (RO1439) and carried out in accordance 
with the Declaration of Helsinki. 
Table 8 Participant flow information 
Participant 
flow variable 
Value Reasoning 
Advertisement        n = 90 1_Time commitment 
responders 2_Ineligible 
  Non-completed n = 8                         1_Not able to do VDT 
participants                                              2_Dropped out 
Completed n = 29              
participants 
 Completed n = 1                         Data appeared to be outlier  
participants  
not analysed 
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Table 9 Participant demographic information 
 
 
 
 
 
 
 
3.3.5 Transcranial direct current stimulation 
Transcranial direct current stimulation (tDCS) was applied using a low 
intensity direct current stimulator (Chattanooga Ionto, Tennessee, USA) and 
delivered via scalp electrodes prepared as follows: Household sponges 
(thickness = 10mm, contact area = 35cm2) were soaked in electrolyte solution 
(NaCl =154mM) and attached to each side of an aluminium foil sheet (area = 
35 cm2) with a rubber band. The anode was positioned over the sensory 
cortex at either the C3’ or C4’ position, which correlated to 2 cm posterior to 
the C3 or C4 position (10-20 EEG system) of the subject’s dominant cortex 
(Ragert et al. 2008). The cathode was placed over the contralateral supra-
orbital region (Ragert et al. 2008). The electrodes were maintained in position 
by a non-conducting elastic strap, which was strapped firmly around the 
subject’s head (Norris, Degabriele & Lagopoulos 2010). For each session, 
tDCS was delivered at a current intensity of 1mA (current density of .02857 
mA/cm2) for 20 minutes. The current density, polarity, and duration of tDCS 
Variable Value 
  Sex 
Male 15 
Female 14 
  Handedness 
Right 24 
Left 5 
  Age (mean in 
yrs +/- SD) 
Range                                                                        
22.86  
(+/- 6.78) 
18-45
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that was applied in this study have all previously been shown to influence 
somatosensory processing in a healthy population (Boggio et al. 2008). 
To quantify any placebo effect there was a control group, which received 
sham stimulation only. This involved activating the tDCS device at a current 
intensity of 1mA but turning the tDCS device off slowly, out of the subject's 
field of view, after ~30 seconds (Gandiga, Hummel & Cohen 2006). The sham 
procedure chosen was based on research that demonstrated that ≤ two 
minutes of tDCS at a current intensity of .02857 mA/cm2 delivered to the 
motor cortex was insufficient to induce alterations post-stimulation to motor 
pathway excitability (Nitsche, Paulus 2000). This approach has previously 
been proven to be reliable at 1 mA for both naive and experienced subjects 
(Ambrus et al. 2012). Stimulation followed the current published guidelines for 
safe use (Nitsche et al. 2008). 
3.3.6 Outcome measure 
3.3.6.1 Vibration Psychophysical thresholds 
This study specifically looked at the ability to detect sinusoidal vibrations, 
which were vertical uni-planar, periodical oscillations applied to the skin 
surface. A signal generator software program (AD Instruments, LabChart 7, 
Australia) generated the sinusoidal waveforms, which were then passed to a 
linear power amplifier (Gearing and Watson, PA30, UK) before being 
delivered to the skin surface via a perspex probe (6-mm-diameter) attached to 
the shaft of a mechanical vibrator (Gearing and Watson, GWV4, UK). The 
mechanical vibrator was mounted on an isolated rigid trunnion (Gearing and 
Watson, T4, UK). The software controlled alterations to both the frequency 
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and voltage amplitude of the sinusoid waveforms. This type of vibration 
system has been used in similar research to the present study (Morley et al. 
2007).  
As the mechanical vibrator system is not feedback controlled, offline 
calibrations were made using a hydraulic micromanipulator (Narishige, MHW-
103, Japan) to identify the amplitude of vibration that is produced (in microns) 
with known settings on the signal generator/amplifier system. 
The subjects were seated upright in a chair and in parallel to the length of a 
rectangular table, which stationed the mechanical vibrator. Foam blocks on 
the table stabilised the subject’s upper limb and helped to keep the hand in a 
pronated position. A measuring tape was used to ensure the same distance 
between foam block and mechanical vibrator for each VDT assessment. The 
investigator then lined the centre of the subject’s distal pad of the third digit on 
the vibrator’s probe tip, which was flush with a 6mm hole in a rigid perspex 
plate (surface area = 30 cm2) suspended from the rigid trunnion. The plate 
limits the spread of surface waves across the skin, and helped to maintain a 
constant indentation of the probe in the skin of the testing site (Stuart et al. 
2003). The probe and the rigid surround were separated by a gap of 2mm. A 
measuring tape was used to ensure that the same site of stimulation was 
used between sessions. The subject was instructed to keep their finger in soft 
contact with the stimulating probe for the testing. Subjects also wore earmuffs 
to avoid any potential auditory cues from the vibration device. 
Vibrations were delivered specifically to the distal pad of the third digit of both 
hands at two different frequencies (30 & 200Hz). These frequencies were 
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chosen to selectively activate different sensory receptors (Kandel, Schwartz & 
Jessell 2000). 30Hz vibrations preferentially activated Meissner corpuscles, 
whereas 200Hz vibrations activated mainly Pacinian corpuscles (Kandel, 
Schwartz & Jessell 2000). Both upper limbs were assessed to measure both 
the contralateral (dominant side) and ipsilateral (non-dominant) side 
responses to brain stimulation of the dominant hand representation (refer to 
Table 10). Site has previously been shown to have influence on tDCS induced 
effects on VDT (Jürgens et al. 2012).  
Table 10 VDT measures 
Parameter Outcome measure 
 Psychophysical 
  
Vibration Dominant_200Hz (D200) 
 Non-dominant_200Hz (ND200) 
 Dominant_30Hz (D30) 
 Non-dominant_30Hz (ND30) 
  
 
VDT was assessed using a method of limits technique (Stuart et al. 2003). For 
each frequency, subjects initially experienced a randomly chosen supra-
threshold vibratory stimulus. The stimulus amplitude was then gradually 
decreased (descending mode) at a constant rate (~1s / stimulus amplitude) 
until the subject verbally indicated that they could confidently no longer detect 
it. After this, the vibratory stimulus was then gradually increased at a constant 
rate (~1s / stimulus amplitude) from a randomly chosen sub threshold level 
(ascending mode) until the subject verbally indicated that they could 
confidently detect the vibration stimulus. The mean of a minimum of 10 
detection thresholds (five ascending and descending) for each frequency and 
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upper limb was calculated for each subject (Stuart et al. 2003). The method of 
limits procedure was selected for measuring vibro-tactile sensitivity as it has 
previously been shown to be more reliable and time efficient than the forced 
choice procedure (Gerr, Letz 1988).  
With respect to timing, VDT was objectively measured both before and after 
tDCS during the first, third and final sessions (i.e. total VDT time points = 6). 
Baseline (i.e. pre-tDCS) VDTs were measured only at time point 1. The 
outcome measures of VDT at each time point included: dominant-30Hz, 
dominant-200Hz, non-dominant-30Hz and non-dominant-200Hz. A practice 
session was also incorporated on day 1. All the measurements were 
performed between 7:45am and 5:30pm. The experimental procedure is 
shown diagrammatically in Figure 2. 
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3.3.7 Data analysis 
Pooled non-transformed VDT means were produced in order to compare 
means with previous literature. 
The primary analysis endpoint (i.e. primary outcome measure) for this study 
was the dominant 200Hz variable outcome measure. The non-dominant 
200Hz, dominant 30Hz and non-dominant 30Hz variable outcome measures 
were secondary analysis endpoints.  
A mixed model analysis of variance (ANOVA) statistical test analysis was 
chosen to test repeated vibration detection threshold measures at six time 
points (see Figure 2) in response to either one of two interventions (active or 
sham tDCS). The time factor represents the “within-subjects” factor, while the 
treatment group is the “between-subjects” factor. Our research hypothesis 
was that there will be a significant interaction effect, and that the subjects in 
the active tDCS would have a greater change over time in the between-
subjects factor. 
In the presence of a significant interaction, the analysis was refined by using 
the syntax features of SPSS to allow a simple main effects analysis with Sidak 
post hoc test for the interaction effect (Peat, Barton 2014).  
Sidak adjustment was used for repeated measures of individual test condition 
(e.g. dominant 200Hz), as Sidak adjustment is not affected as much by loss of 
statistical power for which Bonferroni adjustments are affected by (Dmitrienko, 
D’Agostino 2013).  
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If the interaction effect between the within-subjects and between-subjects 
factor was not significant, the interpretation of the analysis was reverted to 
interpreting the main effects for both factors (i.e., the "within-subjects" factor 
and "between-subjects" factor). In addition, if the main effect of time was 
statistically significant, output from Sidak post hoc tests were interpreted to 
understand where the differences between factors lie. 
Mixed models analysis of variance requires the following assumptions to be 
satisfied: 
• The assumption of normality for the repeated measures 
• The assumption of sphericity for the within-subjects factor for the repeated 
measures 
• The assumption of homogeneity of variance for the between-subjects factor 
 
The standardised residuals were therefore checked to determine if they were 
approximately normally distributed, through Shapiro-Wilk’s test for normality 
or visually through histograms.  
The homogeneity of variance assumption was assumed if Fmax was less than 
10 or Levene’s test of equality of error variances was not significant (sig if p 
<.05) (Tabachnick, Fidell 2007).  
Huyn-Feldt or Greenhouse-Geisser Epsilon corrections were used if 
Mauchly’s test for sphericity was significant. Greenhouse-Geisser Epsilon 
correction was used if the estimated epsilon was <0.75 whereas Huyn-Feldt 
Epsilon correction was used if the estimated epsilon was >0.75.  
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Partial eta-squared (indicated by ηp²) was used as an estimated measure of 
effect size (Allen, Bennett 2012). 
An independent samples t-test was used to compare mean VDT between 
groups at baseline to ensure equivalent baseline characteristic between 
groups after randomisation had occurred. 
Percentage change from baseline following 1 and 5 tDCS sessions within 
groups was also assessed. A percentage change from baseline value 
assessment was performed to enable comparisons in findings with recent 
systematic reviews (Vaseghi, Zoghi & Jaberzadeh 2014). 
A p-value of ≤0.05 was considered significant for significance tests. For each 
analysis, IBM SPSS 20.0 for Windows was used. 
 
3.4 Results 
Pooled non-transformed VDT means (± standard error of the mean) were 
produced (refer to Figure 3). 
D200, ND200 and D30 violated the assumption of normality and were 
therefore transformed (i.e. reciprocally or logarithmically) in order to meet the 
normality assumption (refer to Table 11).
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The ANOVA demonstrated no statistically significant between (i.e. factor = 
treatment) group differences (refer to Table 11). In contrast, the ANOVA 
demonstrated statistically significant within-subjects (i.e. factor = time) 
differences for D200 (p = .04) and ND30 (p = .03). The partial eta-squared 
effect size was medium for the effect of time for D200 and ND30. In line with 
marginal significance, post hoc pairwise comparisons were not significant 
following Sidak adjustment. However, the ANOVA also showed a statistically 
significant time x group interaction for D200 (p = .01). Certain post hoc 
comparisons were significant and demonstrated that there was a significant 
lowering in D200 at time point 6 compared to time points 1 (p = .03), 2 (p = 
.03) and 3 (p = .01) for active tDCS only (refer to Table 12). The partial eta-
squared effect size was medium for the interaction effect for D200. 
No statistically significant differences in baseline mean VDT between the 
groups (active – sham) was observed.  
The range of the pooled mean percentage change from baseline values at 
time points 2 and 6 is listed below: 
x Time point 2:  
o Anodal; -2.1 to -7.5  
o Sham; -2.2 to -7.4 
 
x Time point 6:  
o Anodal; -8.2 to -20.7  
o Sham; -8.1 to +0.7 
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3.5 Discussion 
With respect to detection thresholds, the mean detection thresholds obtained 
in this study for both high and low frequency vibrations were smaller than 
those obtained by Stuart et al. (2003) but comparable to results reported by 
Morley and Rowe (1990). Direct comparisons of thresholds described here 
and those reported by others using a similar vibration set up are difficult due 
to methodological differences such as contact conditions. VDTs for vibrations 
delivered at both high and low frequencies to the finger can be affected by 
contact conditions such as the stimulation probe size and the size of the gap 
between contactor and rigid surround (Morioka, Whitehouse & Griffin 2008). If 
we compare the present study vibration set up to Stuart et al. (2003), the 
stimulation probe size was bigger and the size of the gap between contactor 
and rigid surround was smaller. 
With respect to the first aim of this study that compared the effects of 
consecutive daily sessions of tDCS on VDT compared to sham tDCS, the 
results demonstrated no statistical between-group differences. This is in line 
with the literature where previous studies have failed to show an effect of a 
single session tDCS on VDT compared to sham tDCS in a healthy population 
(Bachmann et al. 2010, Grundmann et al. 2011). More stringent methodology 
for measuring vibro-tactile sensitivity such as using a software controlled 
mechanical vibrator instead of tuning forks and using a method of limits 
approach for sensory testing instead of only vibration disappearance 
thresholds could increase the validity of results. The findings are also in line 
with recent literature that failed to show an effect of a single session tDCS on 
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vibration discrimination thresholds compared to sham tDCS in a healthy 
population (Hanley, Tommerdahl & McGonigle 2015).  
The findings therefore ultimately suggest that increasing stimulation frequency 
(i.e. using repeated daily tDCS) appears not to influence the effectiveness of 
tDCS on VDT in a healthy population. This is therefore not in line with 
previous literature that suggested that repeated daily tDCS might have 
cumulative effects on neuroplasticity induction in a healthy population (Alonzo 
et al. 2012, Reis et al. 2009).  
Reasons why there was a lack of significant tDCS induced effects on vibro-
tactile sensitivity reported in our study may be due to key methodological and 
study design limitations. These include intervention related limitations, 
intervention timing, population type and outcome measure settings and timing. 
Discussion around these parameters is further detailed in Chapter 4. 
Exactly how tDCS may affect sensory function in a healthy population is not 
fully understood.  tDCS has previously been shown to alter the excitability of 
the sensory cortex in a polarity-dependent manner (Dieckhöfer et al. 2006). 
tDCS induced changes to sensory behavior may therefore be the result of 
alterations to task specific cortical networks, which may involve changes to 
synaptic efficiency and the level of cortical excitability within the stimulated 
body part representation in the somatosensory cortex (Nitsche et al. 2004, 
Tegenthoff et al. 2005). Further research appears to be required before firm 
conclusions can be made regarding the mechanisms of tDCS post stimulus 
effects on somato-sensory processing.  
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With respect to the secondary aim of this study, the results demonstrated that 
there was a significant effect of time for tDCS induced effects on ND30 and 
D200. However, in the case of D200, the effect of time was only significant 
depending on group.  These findings agree and disagree with previous 
literature that did or did not show an effect of time for single session tDCS on 
VDT (Bachmann et al. 2010, Grundmann et al. 2011). However, it can be 
seen that for both active and sham tDCS groups there was a steady reduction 
in 30Hz VDTs for both sides (i.e. ipsilateral and contralateral to tDCS) over 
time (refer to Figure 3). These findings possibly suggest that a training effect 
may have been present for 30Hz VDT. Hence, further research is required 
that more appropriately takes into account potential training effects before 
stronger conclusions surrounding the influence of time on tDCS induced 
effects on VDT can be made. 
Both upper limbs were assessed to measure both the contralateral (dominant 
side) and ipsilateral (non-dominant) side responses to brain stimulation of the 
dominant hand representation. It is important to note that outcome measure 
side (i.e. ipsilateral vs. contralateral to tDCS) has been shown to have 
influence on tDCS induced effects on VDT (Jürgens et al. 2012). In addition, it 
is known that 30 & 200Hz vibratory stimuli selectively activate different 
sensory receptors (Kandel, Schwartz & Jessell 2000). Vibrations of 30Hz 
preferentially activate Meissner corpuscles, whereas 200Hz vibrations have 
been reported to mainly activate Pacinian corpuscles (Kandel, Schwartz & 
Jessell 2000). Although the research did not primarily aim to establish which 
side (i.e. dominant or non-dominant) or frequency of vibration have influence 
on tDCS induced effects on VDT, the results suggest that side and frequency 
    75 
of vibration may have influenced tDCS induced effects on VDT. For example, 
a statistically significant effect of time was found on one side only for each 
vibration frequency. Further research is required before conclusions relating 
to the influence of outcome measure side or receptor activation on tDCS 
induced effects on VDT can be drawn.    
With respect to percentage change from baseline, values following 1 or 5 
tDCS sessions in this study were generally minimal in the negative direction. 
However, percentage change from baseline values following anodal tDCS 
were slightly higher in magnitude than those following sham tDCS. These 
findings are similar to previously reported single session sensory cortex tDCS 
induced percentage change from baseline mechanical sensory threshold 
changes (see Chapter 2). Interestingly, percentage change from baseline 
values following anodal tDCS were slightly higher in magnitude at time point 6 
compared to time point 2.  
 
3.6 Limitations 
There are a number of methodological issues that need to be addressed. 
Firstly, the study was conducted on predominantly a young university student 
population. Hence, the results from this study may not necessarily translate to 
other age groups. Secondly, the outcome measures were also performed only 
at one anatomical location (i.e. finger). The results from this study may 
therefore also not necessarily translate to other body parts (e.g. lower limb). 
Thirdly, due to limitations in resources to finance equipment or additional 
personnel, the participants were blinded to treatment group but the researcher 
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was not blinded. Obviously, this increased possibility for bias. Finally, Sidak 
adjustment was used for repeated measures of separate test conditions, as it 
is not affected as much by loss of statistical power for which Bonferroni 
adjustments are affected by. It can be argued that the 4 test conditions can be 
considered as separate entities and therefore not requiring further restrictive 
multiplicity penalisation of the model (Dmitrienko, D'Agostino 2013). 
 
3.7 Conclusion 
In summary, this is the first study that has demonstrated that consecutive 
daily sessions of sensory cortex tDCS cannot consistently modify vibro-tactile 
sensitivity in a healthy human population compared to sham tDCS. The 
findings are in line with previous single session tDCS literature therefore 
ultimately suggesting that increasing tDCS dose (i.e. repeated daily) does not 
overtly influence end results.  
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3.8 Study 2 
 
Modulation of experimental pain perception by transcranial direct current 
stimulation in healthy adults. 
Brookes Folmlia, Peter Johnsona, Wayne Hinga, Allan Abbotta,b,c 
aFaculty of Health Science and Medicine, Bond University, Australia. 
bDivision of Physiotherapy, Department of Neurobiology, Care Sciences and 
Society, Karolinska Institutet, Stockholm, Sweden. 
cDepartment of Physiotherapy, Karolinska University Hospital, Stockholm, 
Sweden. 
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3.9 Abstract  
Background: A number of trials have explored the effects of single session 
tDCS induced effects on pain related measures in a healthy population. 
Recent systematic reviews point out heterogenous treatment effects for such 
trials. Multiple tDCS dose strategies may help deliver more efficacious tDCS 
induced effects on such measures. 
Aims: The aims of the study were twofold. The primary aim was to investigate 
the potential effects of five consecutive daily sessions (1 session / treatment 
day) of motor cortex tDCS on both psychophysical thresholds (e.g. sensory 
detection and pain thresholds in response to electrical, pressure and thermal 
stimulation of the body) and subjective pain intensity scores (i.e. electrical, 
pressure and thermal body pain visual analogue scales (VAS)) in a healthy 
human population. The secondary aims of the study included firstly to 
investigate the effects of five consecutive daily sessions of tDCS on objective 
pain related hormones/neuropeptides (i.e. salivary cortisol, substance P) after 
experimental pain stimulation and then to explore the correlations between 
baseline psychophysical, subjective and objective measures.   
Methodology: Randomised controlled trial methodology was used to assess 
five consecutive daily sessions of either active (anodal) or sham dominant 
motor cortex tDCS on pain related psychophysical, subjective and objective 
outcome measures in 42 healthy volunteers (mean age +/- SD = 24.95 +/- 
7.22; males = 14, females = 28). Possible within-subjects (i.e. factor = time) 
and between-subjects (i.e. factor = treatment) statistical differences for 
psychophysical and subjective outcome measures were examined using the 
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mixed model ANOVA. Possible within- and between-group differences for the 
objective outcome measure were analysed using statistical t-tests. Cross-
sectional analysis of baseline data was also used to explore bivariate 
correlations between examined baseline outcome measures. 
Results: A statistically significant between-subjects difference was observed 
when comparing the mean psychophysical threshold at all time points for one 
psychophysical threshold variable (i.e. CPT) only. The group mean estimates 
indicated that the active group had higher transformed CPT compared to the 
sham group. ANOVA demonstrated no statistically significant within-subjects 
differences as well as no significant time x treatment interaction effect. 
Results showed no statistically significant between-group differences for the 
objective outcome measure. Statistically significant correlations between 
psychophysical and subjective baseline outcome measures were found. 
Conclusions: Increasing stimulation dose (e.g. repeated daily) does not 
consistently influence anodal motor cortex tDCS effects on experimental pain 
perception. As well, the results of the study may provide further evidence of 
the clinical utility of different types of pain assessments. 
 
3.10 Introduction 
Advancements in neuroscience methods have led to increasing use of non-
invasive brain stimulation techniques in neuroscience research. One of these 
techniques, namely transcranial direct current stimulation (tDCS), can achieve 
nervous system modulation by delivering a weak (<2mA) direct current via 
surface electrodes (see (Nitsche et al. 2008) for review).  
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Psychophysical measures can give an indication of sensory and pain 
threshold changes while self-report scales (i.e. numeric or visual analogue) 
can allow subjective rating of pain intensity (Bachmann et al. 2010, Boggio et 
al. 2008, Jürgens et al. 2012). Measuring tDCS induced effects on these 
measures, in a healthy population, provides a rationale for potential 
therapeutic use of tDCS in the treatment of pain.  
A systematic review identified that a number of studies have investigated the 
effects of motor cortex tDCS on pain related psychophysical and subjective 
measures in a healthy human population (see Chapter 2). The studies were of 
good methodological quality but the single session tDCS induced percentage 
change from baseline values were mostly minimal and inconsistent for 
psychophysical measures and mostly moderate (i.e. 20-30%) for subjective 
measures.  
Research has previously indicated cumulative effects on neuroplasticity 
induction (i.e. relating to changes to motor pathway excitability and behavior) 
following the use of repeated daily tDCS in a healthy population (Alonzo et al. 
2012, Reis et al. 2009). Larger and more consistent effects on pain related 
psychophysical and subjective measures in a healthy population may 
therefore require the use of repeated daily motor cortex tDCS. 
Consequently, the aims of this study were twofold: 
1_The primary aim was to investigate the potential effects of five 
consecutive daily sessions (1 session / treatment day) of tDCS on 
psychophysical (i.e. electrical, thermal and mechanical detection and 
pain thresholds) and subjective (i.e. electrical, thermal and mechanical 
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pain visual analogue scales) measures in a healthy human population. 
Nitsche and Paulus (2001) demonstrated that anodal tDCS can 
increase the level of human motor pathway excitability. It was therefore 
hypothesised that consecutive daily sessions of anodal tDCS would 
effectively result in a greater lowering of sensory detection thresholds 
and subjective pain ratings, as well as a greater increase of pain 
thresholds over time compared to sham. 
2_The secondary aims of the study included firstly to investigate the 
effects of five consecutive daily sessions of tDCS on objective pain 
related hormones/neuropeptides (i.e. salivary cortisol, substance P) 
after experimental pain stimulation and then to explore the correlations 
between baseline psychophysical, subjective and objective measures. 
Anodal tDCS has previously been shown to lower cortisol compared to 
sham tDCS (Binkofski et al. 2011). It was therefore also hypothesised 
that anodal tDCS would lower levels of cortisol and substance P after 
experimental pain stimulation compared to the effects of sham motor 
cortex tDCS in a healthy human population 
 
3.11 Material and methods 
3.11.1 Study design 
A prospective randomised single blinded controlled trial was instituted 
involving one experimental and one sham control group.  
With respect to randomisation, subjects were allocated to their respective 
groups through random concealed allocation. The randomisation procedure 
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involved concealed pieces of paper, which had a noted intervention (i.e. active 
or sham). However, stratification of gender between groups was not 
implemented before randomisation.  
3.11.2 Setting 
The following research was carried out in a quiet, controlled and appropriate 
University research laboratory.  
3.11.3 Sample size power calculation 
An a priori sample size power analysis was used to calculate required sample 
size to test ANOVA within-subjects factor (3xtime points) and between-
subjects factor (2xtreatment group) interactions.  Using G*Power software, 
eta-squared was used to calculate effect size (f) for ANOVA (Prajapati et al. 
2010). Aslaksen, Vasylenko and Fagerlund (2014) previously reported eta-
squared values in the range of .07 to .33 for significant tDCS induced effects 
on experimental pain. Considering 95% statistical power, a two sided α =.05 
and a ‘moderate’ effect size = 0.27 a total of n=36 were required (Faul et al. 
2007, Cohen 1992).  
3.11.4 Participants 
Table 13 reveals participant flow information. Subjects (n=42) were allocated 
into an experiment (n=24) group and a control (n=18) group. The subjects in 
the experimental group received anodal tDCS. Subjects were recruited from 
the staff and student population at Bond University and the Gold Coast 
community. Table 14 reveals participant demographic information. 
Participants were given written and oral information regarding the 
investigation (see Appendix 4). People were excluded from participation if 
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they: had any metallic or magnetic pieces inside the brain/skull (except 
titanium); had any implanted metal devices; had epilepsy or have ever 
experienced a convulsion or seizure; consume heavy amounts of alcohol (e.g. 
+4 standard drinks/day) very regularly; had any recent or severe heart 
disease or were possibly pregnant (see Appendix 5). Participation was 
voluntary and all subjects provided written informed consent prior to inclusion 
into the study (see Appendix 6). The participants were recruited between 
September 2013 and June 2014. The study was approved by the Bond 
University Human Research Ethics Committee (RO1693) and carried out in 
accordance with the Declaration of Helsinki. 
 
 
Table 13 Participant flow information 
 
 
 
Participant 
flow variable 
Value Reasoning 
Advertisement        n = 142 1_Time commitment 
responders 2_Ineligible 
  Non-completed n = 1                         Participant dropped out 
participants 
Completed n = 41              
participants 
 Completed n = 1                         pH indicator revealed a saliva  
participants                                              sample that was acidic  
not analysed 
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Table 14 Participant demographic data 
 
 
 
 
 
 
 
 
3.11.5 Transcranial direct current stimulation  
Transcranial direct current stimulation (tDCS) was applied using a low 
intensity direct current stimulator (Chattanooga Ionto, Tennessee, USA) and 
delivered via scalp electrodes prepared as follows: Household sponges 
(thickness = 10mm, contact area = 35cm2) were soaked in electrolyte solution 
(NaCl =154mM) and attached to each side of a carbon rubber electrode (area 
= 35 cm2) with a rubber band. The anode was positioned at either the C3 or 
C4 position (10-20 EEG system) of the subject’s dominant cortex. The 
cathode was placed over the contralateral supra-orbital region (Ragert et al. 
2008). The electrodes were maintained in position by a non-conducting head 
strap, which was strapped firmly around the subject’s head (Norris, 
Degabriele & Lagopoulos 2010). For each session, tDCS was delivered at a 
current intensity of 2mA (current density of .0571 mA/cm2) for 30 minutes. The 
current density, polarity, and duration of tDCS that was applied in this study 
Variable Value 
  Sex 
Male 14 
Female 28 
  Handedness 
Right 38 
Left 4 
  Age (mean in 
yrs +/- SD) 
Range 
24.95  
(+/- 7.22) 
18-46 
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have all previously been shown to influence somatosensory processing in a 
human population (Fregni et al. 2006b).  
To quantify any placebo effect there was a control group, which received 
sham stimulation only. This involved activating the tDCS device at a current 
intensity of 2mA but turning the tDCS device off slowly, out of the subject's 
field of view, after ~30 seconds (Gandiga, Hummel & Cohen 2006). The sham 
procedure chosen was based on research that demonstrated that < two 
minutes of tDCS at a current intensity of .02857 mA/cm2 delivered to the 
motor cortex was insufficient to induce alterations post-stimulation to motor 
pathway excitability (Nitsche, Paulus 2000). Stimulation followed the current 
published guidelines for safe use (Nitsche et al. 2008). 
3.11.6 Outcome Measures 
The outcome measures used for this study are arranged into 3 study 
objectives in line with the primary and secondary aims mentioned previously.  
Thus the following sections are as follows:  
1) tDCS effects on psychophysical threshold and subjective VAS 
measures (refer to Table 15) 
2) tDCS effects on objective measures (refer to Table 15) and  
3) correlations between baseline psychophysical threshold, subjective 
and objective measures.  
The proceeding data analysis, result and discussion sections are similarly 
categorised. 
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Table 15 Psychophysical, subjective and objective outcome measures 
Parameters Outcome 
measures 
  
 Psychophysical Subjective Objective 
Electric EDT  Cortisol 
 EPT EPT_VAS Substance P 
Mechanical PPT PPT_VAS  
Thermal CPT CPT_VAS  
 CTT CTT_VAS  
3.11.6.1 tDCS effects on psychophysical threshold and subjective VAS 
measures 
This study specifically looked at sensory detection and pain thresholds to 
electrical, mechanical pressure and thermal stimuli. The International 
Association for the study of Pain definitions of pain and pain thresholds were 
used as a framework for our pain threshold measurements. Thresholds to 
electrical, mechanical pressure and thermal stimuli were assessed using a 
method of limits technique in order to minimize number of stimuli per pain 
measurement (Boggio et al. 2008, Rolke et al. 2006, Neziri et al. 2011b).  
3.11.6.1.1 Electric psychophysical thresholds  
A computer software program (AD Instruments, Lab Chart 7, Australia) was 
used to generate constant current electrical pulses (pulse duration = 200 
microseconds; maximum repetition rate = 100Hz). The electrical pulses were 
then passed to a built-in isolated stimulator (PowerLab, Ad Instruments, 
Model No. ML-856) for isolation from the mains power and delivered to the 
site of stimulation (i.e. skin surface of the dominant index finger) via a 
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stimulating bar electrode (i.e. 2x 9 mm diameter circular skin contacts, which 
were spaced 30 mm apart). The pulse duration that was applied in this study 
has previously been used to demonstrate tDCS induced effects on sensitivity 
to electrical body pain stimuli in a healthy population (Boggio et al. 2008). The 
pulse frequency that was applied in this study has previously been used to 
assess thresholds for electrical pain stimuli (Laitinen, Eriksson 1985).  
Subjects were seated in front of a table that stationed the electrical stimulator 
set up. To ensure a low impedance electrode contact, the tester then 1) 
applied a small amount of electrode paste (Ten20, D.O. Weaver and CO., 
USA) to each stimulating bar electrode skin contact and 2) cleaned the 
subject’s dominant index finger’s skin surface using an alcohol swab. The 
tester then placed the subject’s dominant index finger on the stimulating bar 
electrode skin contacts. The subject was then instructed to keep their finger in 
contact with the stimulating bar electrode using a small amount of force. The 
subject was then blindfolded and wore earmuffs to avoid any potential 
auditory or visual cues from the stimulator set up.  
Prior to application of the electrical stimuli, the subject was told that they 
would need to verbally state 1) when they could first confidently ‘detect’ the 
electrical stimulus and 2) when they could first confidently perceive the 
electrical stimulus as being ‘a prickly sharp unpleasant painful’ sensation. The 
tester then controlled alterations to the amplitude (i.e. mA) of the electrical 
pulses using the abovementioned computer software. Current supply started 
at 0 mA and was increased in steps of 0.1 mA (application rate = .1 mA / 1 
seconds) until the subject could confidently first perceive the stimulus as 
being ‘painful’.  
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The current amplitudes (i.e. mA) when the subject verbally stated that they 
could 1) first confidently ‘detect’ the electrical stimulus (i.e. electrical detection 
threshold = EDT) and 2) first confidently perceive the electrical stimulus as 
being ‘prickly sharp and painful’ (i.e. electrical pain threshold = EPT) were 
then recorded.  The trial was repeated for a total of three times. Each trial, 
however, was separated by a ~30 second non-stimuli period in order to 
prevent ‘wind-up’ (Eide 2000). The mean of 3 ‘detection’ and ‘pain’ thresholds 
could then be calculated.  
3.11.6.1.2 Mechanical psychophysical thresholds  
A hand held computerised pressure algometer (AlgoMed, Israel) was used to 
generate the pressure stimuli that were delivered to the skin surface of the 
subject’s dominant hand (i.e. base of thumb) via a stimulation probe (shape = 
circular; surface area = 1cm2).  
The subjects were seated in parallel to the length of a table, which stationed 
the pressure algometer setup. The subjects were instructed to rest their 
dominant upper forelimb on the table, which assisted in stabilising the 
subject’s upper limb and helped to keep the hand in a supine position. The 
subject was then blindfolded and wore earmuffs to avoid any potential 
auditory or visual cues from the stimulator set up.  
Prior to application of the mechanical pressure stimuli, the subject was told 
that they would need to physically activate a hand held response unit 
(AlgoMed, Israel) with their non-dominant hand when they could first 
confidently perceive the pressure stimulus as being an ‘unpleasant painful 
pressure’ sensation. To avoid lateral rotation of the subject’s dominant upper 
forelimb during pressure application, the tester held the subject’s thumb down 
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to the table using his non-dominant hand. The tester then placed the pressure 
algometer stimulating probe on the stimulation site (i.e. base of thumb, thenar 
eminence). The tester then manually controlled alterations to the amplitude 
(application rate = ~10 kPa/ second) until the subject physically activated the 
hand held response unit. The pressure application rate that was applied in this 
study was chosen to prevent low false threshold results (Jensen et al. 1986). 
The tester looked at the computerised pressure algometer software program 
for real-time visual feedback of the pressure application rate in order to 
maintain pressure application rate throughout pressure application.  
The mechanical pressure amplitude (i.e. kPa) at the point when the subject 
physically activated the hand held response unit (i.e. pressure pain threshold 
= PPT) was then recorded. The trial was repeated for a total of three times. 
Each trial, however, was separated by a ~30 second non-stimuli period. The 
mean of 3 ‘pain’ thresholds could then be calculated.  
3.11.6.1.3 Thermal psychophysical thresholds   
A cold pressor test was used to measure sensitivity to thermal body pain 
stimuli delivered to the subject’s dominant hand. The tester instructed the 
subject to stand next to a table that stationed a plastic container filled with ice 
saturated water (temperature of water = 0-1 degrees celsius) and then 
marked the subject’s wrist on their dominant upper limb using a marker pen. 
The water temperature that was used in this study has previously been used 
to assess thresholds for the cold pressor test (Neziri et al. 2011b).  
Prior to the application of thermal stimuli, the subject was told that they would 
be required to verbally state when they could first confidently perceive the 
stimulus as being ‘a cold unpleasant painful’ sensation. The subject was also 
instructed to withdraw their hand when they could no longer tolerate the 
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stimuli. The subject was further instructed to not 1) clench their fist during the 
cold pressor test, 2) move their hand during the cold pressor test, 3) 
submerge their arm in the ice saturate water (i.e. hand only) and 4) perform 
the test for more than two minutes for consistent administration of the task 
and measurement (Von Baeyer et al. 2005). The subject then placed their 
hand into the ice-saturated water to the level of their wrist markings.  
The time duration (i.e. seconds) when the subject 1) first stated that they 
could confidently perceive the stimulus as being a ‘cold unpleasant painful’ 
sensation (i.e. cold pain threshold = CPT) and 2) withdrew their hand from the 
ice saturated water (i.e. cold tolerance threshold = CTT) was recorded. A 
single ‘pain detection’ threshold and ‘pain tolerance’ threshold could therefore 
be established.  
3.11.6.1.4 Subjective pain visual analogue scales 
To analyse self-reported experimental body pain intensity, a visual analogue 
scale (VAS) with a single line and scoring range from 0 for ‘no pain’ to 100mm 
for ‘pain as bad as you can imagine’ was used. After each individual 
experimental body pain trial, the subject placed a vertical mark on the line to 
indicate the intensity of pain when they first perceived the stimulus as being 
painful or could no longer tolerate the stimuli (see Appendix 7). A pain visual 
analogue scale score could therefore also be calculated for each 
psychophysical threshold measurement. The VAS is the expert advisory panel 
of the World Health Organisation recommended measure for pain (Ehrlich, 
Khalteav 2003). 
All experimentally induced pain assessments were performed before and after 
the first stimulation session, as well as after the final stimulation intervention 
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session (i.e. total time points = 3). There were no defined rest periods 
between the different experimental pain assessments. Baseline (i.e. pre-
tDCS) experimentally induced pain assessments were measured only at time 
point 1. Practice of the detection and pain threshold testing for electrical and 
mechanical stimuli was also incorporated on day 1. All the measurements 
were performed between 9am and 9pm. The experimental procedure is 
shown diagrammatically in Figure 4.  
Prior to any threshold testing on day 1, an assessment of mechano-receptor 
sensory function on the participant’s hands at three different anatomical 
locations (i.e. index finger and thenar and hypo-thenar eminences) was briefly 
performed (see Appendix 8). The participant was blindfolded and asked to 
verbally indicate 1) whether they perceived either a soft (i.e. piece of cotton) 
or sharp object (i.e. needle), 2) what hand they perceived the object contacted 
and 3) whether there was a significant difference in the intensity of the stimuli 
between hands.  
3.11.6.1.5 Self-reported measure of participant blinding awareness  
To analyse participant blinding awareness the participant was first asked to 
answer either yes or no in response to the question “do you believe that you 
just received the real scalp stimulation intervention protocol?”. To further 
analyse participant blinding awareness, a visual analogue scale (VAS) with a 
single line and scoring range from 0 for ‘not confident at all’ to 100mm for 
‘completely confident’ was used (see Appendix 9). The subject was 
additionally asked to place a vertical mark on the line to indicate the level of 
confidence they had in their answer to “do you believe that you have just 
received the ‘real’ scalp stimulation intervention protocol?”. The self-reported 
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measure of participant blinding awareness has previously been used 
(O'Connell et al. 2012).  
3.11.6.1.6 Self-reported measure of scalp stimulation adverse effects  
Completed participants filled in a scalp stimulation adverse effects 
questionnaire (see Appendix 10). The questionnaire instructed participants to 
detail the number of occasions a particular adverse effect occurred.  
3.11.6.2 tDCS effects on objective measures 
3.11.6.2.1 Salivary hormone and neuropeptide 
Participants were asked to provide a saliva sample (~1-2 mL) before the 
stimulation intervention on day 1 and again after stimulation intervention on 
day 5 (i.e. number of saliva samples = 2). Subjects were instructed not to 
consume any food or drink, nor brush their teeth for 1 hr before research 
participation. To minimize any possible effect of diurnal variation, stimulation 
intervention sessions 1 and 5 were conducted at a similar time for each 
subject. Subjects were first instructed to allow saliva to pool in their mouth. 
Subjects were then instructed to tilt their head forward and drool down a piece 
of plastic straw into a collecting tube. The subject repeated this as often as 
necessary till sufficient sample was collected. The participant was allowed to 
physically pretend chewing food (i.e. no physical stimulant was placed in the 
mouth) to help produce a sufficient amount of saliva. All saliva samples were 
stored on ice until handling, at which point the samples were aliquotted. All 
samples were stored at –80°C until use. Upon thawing, the samples were 
centrifuged to ensure debris removal. 
Human cortisol was detected by competitive enzyme-linked immunosorbent 
assay (ELISA) according to manufacturer’s instructions (1-3002; Salimetrics). 
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Human substance P was detected by competitive ELISA according to 
manufacturer’s instructions (133029; Abcam). Most samples were tested 
twice, and the mean for those samples were calculated. 
Pre intervention saliva samples were collected ~45 minutes prior to 
stimulation intervention on day 1. Post intervention saliva samples were 
collected ~ 30 minutes post stimulation intervention on day 5 (refer to Figure 
4). Saliva samples were collected approximately between 9:30 am to 7:30 pm. 
3.11.6.3 Correlations between baseline psychophysical threshold, 
subjective and objective measures 
All abovementioned psychophysical, subjective and objective measures were 
used for this study objective.  
3.11.6.3.1 Self-reported measure of general pain sensitivity 
A self-reported general pain sensitivity questionnaire (SRGPSQ) was also 
used to add more thorough information regarding the participant’s perception 
of pain sensitivity in relation to imagined experiences of pain (see Appendix 
11). The subject was asked to imagine themselves in certain situations and 
determine whether the situations would be painful. If the situation would be 
painful, the participant was then asked to state the situational pain intensity on 
a scale from 1-10 where 0 was ‘no pain’; and 10 ‘the most severe pain that 
you can imagine.’ The administered self-report general pain questionnaire has 
been previously been shown to significantly correlate to experimental pain 
intensity ratings (Ruscheweyh et al. 2009). 
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3.11.7 Data Analysis 
3.11.7.1 tDCS effects on psychophysical threshold and subjective VAS 
measures  
Pooled baseline psychophysical and subjective pain VAS overall, gender 
based and treatment based means were produced in order to compare means 
with previous literature. 
An independent samples t-test was used to test possible between tDCS group 
differences in the mean participant blinding visual analogue scale score in 
order to establish whether the blinding strategy was effective.  
The primary analysis endpoint (i.e. primary outcome measure) was the pain 
visual analogue scales scores, as the visual analogue scale is the expert 
advisory panel of the World Health Organisation recommended measure for 
pain (Ehrlich, Khalteav 2003). The psychophysical thresholds were secondary 
analysis endpoints (i.e. secondary outcome measures). 
A mixed model analysis of variance (ANOVA) statistical test analysis was 
again chosen to test repeated psychophysical threshold/subjective VAS 
measures at three time points in response to one of two interventions (active 
or sham tDCS). Refer to section 3.3.6 for the mixed model ANOVA statistcal 
approach/procedure. 
Percentage change from baseline was again also assessed and a mean 
adverse effects occasion number for each intervention was calculated. 
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A p-value of ≤0.05 was considered significant for significance tests. For each 
analysis, IBM SPSS 20.0 for Mac was used. 
3.11.7.2 tDCS effects on objective measures  
Descriptive statistical analyses were performed (i.e. examining Shapiro-Wilk 
and visually through histograms) to establish that the raw data met 
assumptions of normal distribution and normality for statistical tests.  
Paired t-test analyses were used to assess within-group differences in the 
mean concentrations collected pre and post tDCS for cortisol for each tDCS 
group (active or sham).  
Within-group differences were also assessed with Cohen’s d effect size 
measure where d =0.20 is considered a small effect, d=0.50 a medium effect, 
and d=0.80-infinity a large effect size (Cohen 1992).  
Statistical comparisons of mean baseline and change from baseline salivary 
cortisol concentration between the groups (active – sham) were conducted 
using an independent t-test.   
Statistical comparison of the mean saliva sample 24hr time for each time point 
and change from baseline between the tDCS groups (active – sham) was 
conducted using non-parametric Mann-Whitney U test.  
Percentage change from baseline was also assessed. 
A p-value of ≤0.05 was considered significant and 95% confidence intervals 
are given for significance tests. For each analysis, IBM SPSS 20.0 for 
Windows was used. 
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3.11.7.3 Correlations between baseline psychophysical threshold, 
subjective and objective measures  
Correlations between psychophysical, subjective and objective measures 
were analysed using bi-variate Spearman’s Rho correlation coefficients (see 
Table 20). Correlation coefficients have previously been used to assess 
associations between multiple pain measures (Bhalang et al. 2005, 
Ruscheweyh et al. 2012). 
The strength of the correlation coefficient was valued according to (Domholdt 
2000) who suggested the following scale: .00-.25 = little, if any correlation; 
.26-.49 = low correlation; .50-.69 = moderate correlation; .70-.89 = high 
correlation; and .90-1.00 = very high correlation.  
A p-value of ≤0.05 was considered significant for significance tests. It is 
important to note that the approach to analysing this data was exploratory. 
Hence, p-value adjustment for multiple comparisons was not performed.  
 
3.12 Results 
3.12.1 tDCS effects on psychophysical threshold and 
subjective VAS measures 
 
Pooled baseline psychophysical and subjective pain VAS overall, gender 
based and treatment based means were produced (refer to Table 16). 
An independent samples t-test displayed that there were no statistically 
significant between-groups differences in participant blinding VAS scores 
(active {mean, SD} = 6.35, 2.64; sham {mean, SD} = 7.66,1.52), t(39)= -1.847, 
p = .072). In addition, 23/23 and 17/18 participants answered yes to the 
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participant blinding awareness question following active or sham tDCS 
respectively. Hence, the blinding strategy was deemed effective.   
With respect to descriptive analyses, CPT and PPT had to be logarithmically 
transformed in order to meet normality assumptions for parametric testing 
(refer to Table 17). 
CTT and EDT were not analysed as transformations failed to meet normality 
assumptions for parametric testing. There are two main reasons for this. 
Firstly, there were a number of values on the natural limit for CTT. Secondly, 
there was more than one mode (roughly speaking) for EDT. 
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When comparing mean psychophysical thresholds and subjective pain VAS 
scores between the tDCS groups (active – sham) at all the time points the 
ANOVA demonstrated statistically significant between-groups differences for 
one transformed psychophysical threshold variable (i.e. CPT) (p = .03). The 
group mean estimates indicated that the active group had higher transformed 
CPT compared to the sham group. The partial eta-squared effect size was 
medium for the group effect for CPT. However, the ANOVA did not 
demonstrate statistically significant with-in group (i.e. factor = time) 
differences as well as no significant time x treatment interaction.  
In this study statistically significant group differences at baseline were found 
for PPT. Therefore, PPT was analysed using baseline data as a co-variate to 
adjust for baseline differences.  
The overall range of the pooled mean percentage change from baseline 
psychophysical values at time points 2 and 3 is listed below: 
x Time point 2:  
o Anodal; -7.2 to +10.5  
o Sham; -5.4 to +8.5 
 
x Time point 3:  
o Anodal; -8.9 to +3.2 
o Sham; -7.3 to -0.7 
 
The overall range of the pooled mean percentage change from baseline 
subjective values at time points 2 and 3 is listed below: 
x Time point 2:  
o Anodal; +0.4 to +15.3  
o Sham; -18.5 to +12.2 
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x Time point 3:  
o Anodal; -20.6 to +3.5 
o Sham; -10.5 to +2.1 
 
The scalp stimulation adverse effects questionnaire demonstrated that 
participants in both groups experienced a range of adverse effects (see Table 
18). 
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Statistically significant differences in the mean concentration collected at 
baseline and time point 2 for cortisol were observed for both active (p = <.001) 
and sham (p = .039) groups (refer to Table 19). Paired differences revealing a 
lower mean saliva cortisol concentration at time point 2 for both groups. 
Cohen’s d values for cortisol displayed large and medium effect for active and 
sham tDCS respectively.  
Independent samples t-test analyses displayed that there were no statistically 
significant between-group differences for cortisol in the baseline mean 
concentration and mean concentration change from baseline (p = .063).  
Mann Whitney U test analyses also displayed that there were no statistically 
significant between-group differences in the mean saliva sampling 24hr time 
for each time point (pre: U = 153, p = .347; post: U = 139.5, p = .181) or 
change from baseline (U = 167, p = .585).  
Percentage change from baseline values in this study were ~  -30 and -50 % 
following sham and active tDCS respectively. 
With respect to salivary substance P, the concentration results were hardly 
ever above the lower limit of detection (i.e. only 4 participants per group could 
be analysed). As a result, they were not analysed. 
3.12.3 Correlations between baseline psychophysical 
threshold, subjective and objective measures 
 
Statistically significant correlations between baseline psychophysical 
thresholds for EDT, EPT, PPT, CPT and CTT (e.g. CPT_1 & CTT_1) were 
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observed. Spearman’s Rho correlation coefficient values (r) displayed positive 
low, moderate and high correlations for statistically significant correlations. 
Statistically significant correlations between baseline subjective pain VAS 
scores for EPT, PPT, CPT and CTT (e.g. EPT_V_1 & CPT_V_1) were 
observed. Spearman’s Rho correlation coefficient values (r) displayed positive 
moderate and high correlations for statistically significant correlations.  
Statistically significant correlations between baseline psychophysical 
thresholds and baseline subjective pain VAS scores were observed for EDT & 
CPT_V and CTT & CTT_V. Spearman’s Rho correlation co-efficient values (r) 
displayed either negative moderate or positive low correlations for statistically 
significant correlations.  
Correlations between SRGPSQ scores and all psychophysical, objective and 
other subjective assessments were not statistically significant.  
As well, correlations between baseline salivary cortisol levels and all 
psychophysical and subjective assessments were not statistically significant.
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3.13 Discussion & Conclusions 
3.13.1 tDCS effects on psychophysical threshold and 
subjective VAS measures 
 
With respect to mean baseline psychophysical thresholds, direct comparisons 
of thresholds described here and those reported in previous research using 
psychophysical sensory thresholds are difficult due to methodological 
differences (e.g. stimulation site, frequency and application rate) (see Table 
16). The mean overall EDT (i.e. ~0.9mA) & EPT (i.e. ~1.8mA) values 
described here were distinctly smaller than body side based mean values 
reported by Laitinen and Eriksson (1985) (i.e. EDT = ~1.5-2mA; 
EPT=~3.5mA). The gender based mean CPT (i.e. females = ~10s, males = 
~16s) values measured in our research were smaller than those obtained by 
Tashani, Alabas and Johnson (2010) (i.e. females = ~16s, males = ~24s). The 
mean gender based CTT (i.e. females =~46s, males = 58s) values were also 
distinctively higher than those reported by Neziri et al. (2011b) (i.e. females 
=~35s, males =39s). The mean overall PPT values (i.e. ~180 kPa) reported 
from our study were also distinctly smaller than those obtained by Rolke et al. 
(2006) (i.e. 400 kPa).  
With respect to tDCS effects on psychophysical thresholds, no statistically 
significant within-subjects (i.e. factor = time) differences were found. In 
contrast, a statistically significant between-subjects (i.e. factor = treatment) 
difference was observed for CPT only. The results therefore do not support 
our hypothesis that the use of consecutively daily sessions of anodal motor 
cortex tDCS would result in significantly lower electrical detection thresholds, 
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and higher electrical, thermal and mechanical pain thresholds compared to 
the effects of sham in a healthy human population.  
The significant between-subjects finding for CPT is in agreement with former 
controlled tDCS studies in healthy volunteers (Grundmann et al. 2011, 
Hansen et al. 2011, Bachmann et al. 2010, Jürgens et al. 2012, DosSantos et 
al. 2014). The non-significant between-subjects finding for PPT is also in 
agreement with existing research on controlled tDCS studies in healthy 
volunteers (Grundmann et al. 2011, Bachmann et al. 2010, Jürgens et al. 
2012, Vaseghi, Zoghi & Jaberzadeh 2015a). In contrast to the present study 
interaction findings, Boggio et al. (2008) was able to demonstrate that 
stimulation type can influence tDCS induced effects on EPT over time.   
There are a number of possible methodological reasons why a statistical 
significant between-subjects difference was seen for CPT and not other 
psychophysical thresholds. Firstly, the stimulus intensity (i.e. related to 
temperature) was not purposefully altered during CPT. The CPT may 
therefore preferentially activate afferent C fibres. In contrast, EPT and PPT 
are none preferential meaning that all afferent fibres (i.e. a-beta, a-delta) are 
activated sequentially with increasing stimulation intensity. Secondly, CPT 
had a larger stimulation area (i.e. hand) compared to EPT and PPT (i.e. 
finger). Thirdly, CPT was always the final psychophysical threshold test (i.e. 
after either EPT or PPT) in each experimental pain testing block. Hence, we 
cannot rule out sequence effects. Ultimately, the research suggests the need 
for further research before task dependent effects can be elucidated. 
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Exactly how motor cortex based non-invasive brain stimulation may affect 
pain function in a healthy population is not fully understood. Several 
mechanisms are proposed. Motor cortex tDCS could alter sensory 
discriminative components of pain by influencing descending cortico-thalamic 
pathways. Polania, Paulus and Nitsche (2012) demonstrated that motor 
cortex anodal tDCS could alter functional coupling between the ipsilateral 
motor cortex and thalamus in a healthy population. As well, motor cortex 
tDCS could alter pain related outcome measures by influencing descending 
opioid-based anti-nociception. Motor cortex tDCS can affect descending 
opioid-based anti-nociception via activation of several opioid rich central 
nervous system sites such as the thalamus, peri-aqueductal grey, precuneus 
and prefrontal cortices (DosSantos et al. 2014). Hence, tDCS may alter pain 
function in a healthy population via influencing a range of pain related nervous 
system regions.  
With respect to percentage change, percentage change from baseline values 
in this study for psychophysical thresholds were mostly minimal (i.e. typically 
less than or equal to 10 percent), which is in line with the findings of our 
systematic review (refer to Chapter 2). 
With respect to mean baseline subjective thresholds, the mean baseline 
gender based CTT_V values (i.e. males and females = ~7cm) described here 
were similar to those obtained by Mitchell, MacDonald and Brodie (2004) 
(males =~7.5; females = ~8cm). The mean baseline treatment based CPT_V 
values (i.e. active and sham tDCS = ~3.5cm) described here were smaller 
than cold pressor test VAS values obtained by Hamner et al. (2014) (i.e. 
active and sham tDCS = ~6.5cm). However, Hamner et al. (2014) VAS values 
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represented the 30 second averaged pain VAS score.  The mean baseline 
treatment based EPT_V values (i.e. active and sham tDCS = ~3.5cm) were 
similar to the EPT pain intensity ratings obtained by Hansen et al. (2011). 
However, Hansen et al. (2011) used numeric rating scales instead of pain 
visual analogue scales to assess pain intensity. 
With respect to tDCS effects on subjective pain intensity measures, no 
statistically significant between-subjects or within-subjects differences were 
observed for any subjective measure. The results thus do not support our 
hypothesis that the use of anodal motor cortex tDCS would effectively lower 
subjective pain intensity ratings compared to the effects of sham in a healthy 
human population.  
Previous literature investigating the effects of tDCS on subjective pain 
intensity has demonstrated conflicting findings. The non-significant findings 
are in agreement and disagreement with former controlled tDCS studies in 
healthy volunteers (Jürgens et al. 2012, Hansen et al. 2011, Terney et al. 
2008).  
Methodological differences may help to explain the contrasting results. For 
example, Hamner et al. (2014) recently demonstrated significant tDCS 
induced reductions in average cold pressor ratings compared to sham when 
assessing average cold pressor ratings at a water temperature of 14 degrees 
and not 0 degrees. Hence, it could be suggested that future related studies 
that investigate the effects of consecutive daily tDCS on pain perception use 
different variable settings for each examined modality. This would enable 
stronger conclusions to be made about the effectiveness of consecutive daily 
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tDCS on experimental pain. 
Percentage change from baseline values in this study for subjective ratings 
were marginally higher compared to those for psychophysical thresholds (i.e. 
typically greater than 15 percent), which is also in line with the findings of our 
systematic review and previous research (Aslaksen, Vasylenko & Fagerlund 
2014).  
With respect to participant blinding, no significant between-group differences 
in mean participant blinding awareness suggests that the participant blinding 
strategy was effective. The findings are therefore in contrast to research that 
has previously demonstrated inadequate blinding of tDCS when delivered at 
2mA to the motor cortex (O'Connell et al. 2012).  Differences in stimulator 
devices used and study designs (i.e. parallel vs. cross over) may help to 
explain finding differences when comparing O’Connell et al. (2012) and the 
present study. However, the present study results are in line with a number of 
other studies that have since provided evidence that seems to indicate that 
participants could not distinguish between active and sham tDCS delivered at 
2mA to either the frontal or motor cortices (Ihle et al. 2014, Palm et al. 2013, 
Russo et al. 2013). Further research into the development of more suitable 
sham techniques may therefore be required to improve methodological 
quality.  
With respect to adverse effects, the findings are similar to Russo et al. (2013) 
but different to Kessler et al. (2012).  Differences in tDCS parameters (e.g. 
current intensity, stimulation duration) may account for literature 
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inconsistencies. Further research into adverse effect occurrences between 
active and sham tDCS is therefore also required. 
3.13.2 Limitations 
There are methodological issues that need to be addressed. The study was 
conducted on predominantly young aged university students. Hence, the 
results from this study may not necessarily translate to other population age 
groups. Secondly, the participants were blinded to treatment group but the 
researcher was not blinded due to limitations in resources to finance 
equipment or additional personnel. Obviously, there is increased possibility for 
bias in a single blinded trial compared to a double blinded trial. Thirdly, gender 
imbalances occurred within the study groups. Consequently, gender based 
variability may have influenced results. Hence, future related trials should be 
double blinded and better designed to include gender differences.  
3.13.3 Conclusion  
Consecutive daily sessions of anodal motor cortex tDCS do not appear to 
have a cumulative effect on experimental pain perception measures in a 
healthy population.  
3.13.4 tDCS effects on objective measures 
With respect to within- and between-groups statistical comparison of saliva 
concentrations, both anodal and sham motor cortex tDCS significantly 
reduced levels of salivary cortisol compared to baseline post experimental 
pain stimulation but there were no significant between-group differences. The 
results therefore do not agree with our hypothesis that consecutive daily 
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sessions of anodal motor cortex tDCS would alter salivary levels of cortisol 
compared to sham post experimental pain stimulation.  
The within-group cortisol results (i.e. significance compared to baseline) are in 
agreement with a prior controlled tDCS study in a healthy population 
(Raimundo, Uribe & Brasil-Neto 2012). However, the between-group cortisol 
result (i.e. no significance compared to sham) is in disagreement with prior 
controlled tDCS studies (Brunoni et al. 2013, Sarkar, Dowker & Kadosh 
2014).  
Possible explanations for the contrasting results may relate to the site of 
stimulation or context of the stress response. For example, research has 
previously demonstrated that a single session of anodal pre-frontal cortex 
tDCS modulated the effects of arithmetic decision on salivary cortisol 
compared to sham (Sarkar, Dowker & Kadosh 2014). Further research is 
therefore required to investigate the influence of stimulation site or context of 
stress response on tDCS induced effects on cortisol.  
Another reason for the contrasting results may relate to power. The results 
showed a trend toward significant between group differences (i.e. the active 
tDCS group displayed a considerable larger effect size and smaller level of 
significance compared to the sham tDCS group). It could therefore be argued 
that the study was underpowered to achieve between group significance. 
Perhaps a larger sample size would have yielded group significance.   
The lowering in cortisol compared to baseline may therefore reflect a stress 
response to new procedures; baseline cortisol was measured prior to tDCS 
and psycho-physical testing whereas follow up cortisol was measured post 
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tDCS and psycho-physical testing (Raimundo, Uribe & Brasil-Neto 2012). 
Future studies should therefore have more appropriate timed cortisol 
measures. 
Alternatively, the lowering in cortisol compared to baseline may be due to 
circadian variation of cortisol levels (Dorn et al. 2007, Baeken et al. 2009). No 
statistically significant between-group differences in saliva sampling 24hr time 
for each time point and change from baseline in our study however suggests 
that circadian variation is not an issue in our study.  
With respect to percentage changes, the magnitude and direction of 
percentage change from baseline cortisol values following anodal and sham 
tDCS was similar to those previously reported using single session tDCS 
(Binkofski et al. 2011). 
It is also important to discuss how tDCS might have influenced cortisol. Motor 
cortex tDCS could influence stress related central nervous system circuitry. 
Cortisol is an end product of the hypothalamic-pituitary-adrenal (HPA) axis. 
Binkofski et al. (2011) demonstrated that a single session of anodal motor 
cortex tDCS could lower serum cortisol levels compared to sham tDCS in a 
healthy human population. The findings therefore suggest that motor cortex 
tDCS may be able to influence central stress related circuitry such as the 
hypothalamic-pituitary-adrenal (HPA) axis. Future related studies are 
therefore required to investigate the relationship between tDCS and cortisol 
using different mediums (e.g. serum).  
With respect to salivary substance P, the concentration results were hardly 
ever above the lower limit of detection. One possible reason for this may be 
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that peripheral substance P triggered in peripheral experimental pain testing 
protocols may not be long lasting enough to influence salivary concentration 
in many healthy humans.  
3.13.5 Limitations 
There are methodological issues that should be taken into consideration when 
interpreting the results. Participants were not asked to refrain from non-work-
related vigorous physical activity prior to research participation. Previous 
research has demonstrated that physical activity can increase objective pain 
related biomarker levels in the human body (Lind et al. 1996, Lusa Cadore et 
al. 2009). However, no recent vigorous physical activity before testing was 
reported by participants or physically evident when observing participants 
before testing. Furthermore, the study did not control for menstrual cycle 
phase or use of oral contraceptives, which may have influenced salivary 
measurements in females (Kirschbaum et al. 1999). 
3.13.6 Conclusion  
Five consecutive daily sessions of anodal motor cortex tDCS does not 
significantly alter salivary cortisol levels post experimental pain stimulation 
compared to sham. It is suggested that future related studies investigate the 
effects of repeated sessions of anodal pre-frontal tDCS on objective pain 
related outcome measures.  
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3.13.7 Correlations between baseline psychophysical 
threshold, subjective and objective measures 
 
With respect to correlations between psychophysical thresholds, statistically 
significant correlations between baseline psychophysical thresholds were 
observed. The results are therefore in line with previous literature that has 
demonstrated statistically significant correlations between psychophysical 
measures within the same test modality and between different test modalities 
in a healthy population (Bhalang et al. 2005, Neddermeyer, Flühr & Lötsch 
2008, Neziri et al. 2011a). Bhalang et al. (2005) and Neziri et al. (2011a) 
further reported higher correlations between psychophysical measures within 
the same test modality. The highest statistically significant correlation 
between baseline psychophysical thresholds in the present study was also 
observed within the same modality (i.e. EDT and EPT) (see Table 20). A 
higher correlation within the same modality should be expected due to similar 
characteristics of sensation evoked by psychophysical thresholds within the 
same modality (Bhalang et al. 2005). Moreover, the strength and direction of 
correlations between psychophysical measures with in the same test modality 
reported by Bhalang et al. (2005) are comparable with those described in the 
present study.  
The present study also provides evidence for significant correlations between 
baseline subjective VAS assessments within and between modalities, as well 
as between baseline subjective VAS assessments and psychophysical 
thresholds within and between modalities (see Table 20). These findings 
therefore agree and disagree with previous literature. Ruscheweyh et al. 
(2010) demonstrated significant correlations between subjective 
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assessments, as well as between subjective assessments and 
psychophysical thresholds within the same modality. Ruscheweyh et al. 
(2010), however, did not demonstrate significant correlations between 
subjective assessments and psychophysical thresholds between modalities. It 
may be difficult to directly compare results to those reported by Ruscheweyh 
et al. (2010) as the present study incorporated a pain visual analogue scale 
for subjective assessment compared to a numeric rating scale utilised by 
Ruscheweyh et al. (2010). 
The current study further found that SRGPSQ scores did not significantly 
correlate with any baseline psychophysical, subjective or objective 
assessment. The finding that SRGPSQ scores did not significantly correlate 
with baseline psychophysical threshold is in line with previous literature 
conducted in a healthy population (Ruscheweyh et al. 2009). Ruscheweyh et 
al. (2009), however, reported that SRGPSQ scores significantly correlated 
with subjective assessments. Again, it may be difficult to directly compare 
results to those reported by Ruscheweyh et al. (2009) as the present study 
incorporated a pain visual analogue scale for subjective assessment 
compared to a numeric rating scale utilised by Ruscheweyh et al. (2009).  
In summary, the present study provides evidence that baseline salivary 
cortisol levels did not significantly correlate with any psychophysical threshold 
or subjective assessment in a healthy population. These findings are in 
agreement with previous literature that demonstrated no significant 
correlations between thermal (i.e. heat) pain and hormone (i.e. cortisol/ 
dehydroepiandrosterone) plasma levels in healthy women (Yamamotová, 
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Kmoch & Papežová 2012). It therefore appears that salivary/peripheral levels 
of cortisol would not help clinicians interpret pain intensity. 
3.13.8 Limitations 
The study was exploratory. Hence, p-value adjustment for multiple 
comparisons was not performed. 
3.13.9 Conclusions 
Statistically significant correlations between psychophysical thresholds, 
between subjective assessments and between psychophysical thresholds and 
subjective assessments were observed in a healthy population. The observed 
correlations may suggest the clinical utility of different types of pain 
assessments. 
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Chapter 4 
General Discussion & Conclusion  
4.1 Research objectives, key findings and potential 
explanations 
Numerous studies have investigated the effects of transcranial direct current 
stimulation (tDCS) on measures of somatosensory perception in a healthy 
population. However, the systematic review undertaken within this thesis and 
two previous systematic reviews (Vaseghi, Zoghi & Jaberzadeh 2014, 
Vaseghi, Zoghi & Jaberzadeh 2015b) indicated both methodological 
limitations and heterogenous tDCS induced effects for existing trials. These 
three reviews also reported that stimulation frequency (e.g. using repeated 
daily tDCS) was one area that researchers have failed so far to focus their 
attempts on.  
The overall primary purpose of Studies 1 and 2 was therefore to investigate 
the effects of consecutive daily sessions of anodal tDCS on psychophysical, 
subjective and objective outcome measures in a healthy human population. 
Following this, a secondary purpose of Study 2 was to explore correlations 
between baseline psychophysical, subjective and objective outcome 
measures in a healthy population.  
The overall primary finding from Studies 1 and 2 suggests that increasing 
stimulation frequency (e.g. using repeated daily tDCS) does not appear to 
have a cumulative effect on psychophysical (i.e. vibration, electrical, pressure 
and thermal detection and pain thresholds), subjective (electrical, pressure 
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and thermal pain visual analogue scales) and objective (cortisol) measures in 
a healthy human population.  
The results predominantly do not support our hypothesis that five consecutive 
daily sessions of anodal tDCS would significantly lower electrical, vibration 
detection thresholds, heighten electrical, thermal and mechanical pain 
thresholds and lower subjective pain scores (i.e. electrical, thermal and 
mechanical pain visual analogue scales) compared to the effects of sham 
tDCS in a healthy human population. 
There are a number of potential reasons for this that relate predominantly to 
methodology and experimental design. With respect to methods, there are 
certain intervention related limitations such as focality, inter-individual 
variability and strength. As mentioned in the introduction chapter, one tDCS 
limitation is stimulation focality with conventional tDCS potentially producing 
nerve polarization over a large area of brain. Combining tDCS with other 
techniques, which promote activity in related nervous system areas, may have 
therefore been required to achieve more consistent results by improving the 
specificity of tDCS induced neuroplasticity (Cano et al. 2013). In line with this 
hypothesis, Schabrun et al. (2014) demonstrated that combining motor cortex 
tDCS and peripheral electrical stimulation (i.e. applied to the body area of 
most pain) more effectively improved chronic low back pain symptoms in a 
chronic pain population compared to either technique alone or sham tDCS.  
Another key limitation of tDCS is high inter-individual variability in both 
neurophysiological and behavioural responses (Wiethoff, Hamada & Rothwell 
2014).  A number of factors that can modify plasticity induction have been 
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identified, such as age, sex and handedness (Ridding, Ziemann 2010). It is 
therefore plausible to suggest that significant treatment effects may have 
been obtained if we focused on only the one gender or a different aged 
population. Of importance to this thesis, previous research has demonstrated 
that baseline brain metabolite levels predicted the tDCS induced analgesic 
response in a healthy population (Reidler et al. 2012). Consequently, it could 
be hypothesised that investigating tDCS induced effects on experimental pain 
in populations with certain biochemical profiles may also help to achieve more 
consistent results. The abovementioned research highlights the need to better 
understand the individual factors that determine tDCS responsiveness.  
Thirdly, there are no standard protocols/markers to assess effectiveness of 
tDCS strength (or dose) (Priori, Hallett & Rothwell 2009). tDCS strength is 
therefore not individually adjusted. Consequently, it could be hypothesised 
that the use of more individualised tDCS strength parameters may help to 
achieve more consistent results.  
The outcome measures used in this study may have also been another 
methodological factor that influenced findings. Most outcome measures in this 
study were pain related. Pain can be viewed as a dynamic process that can 
be influenced by a number of individual factors. The evaluation of pain can 
therefore be considered as being more complex compared to other 
physiological measures such as evoked potentials, for which tDCS has been 
shown to consistently influence in a healthy population (Ihle et al. 2014, 
Nitsche et al. 2008). 
 
  124 
As well, the research did not investigate tDCS induced effects on 
serum/plasma levels of cortisol or substance P. Previous research has 
demonstrated less variation in serum levels of cortisol compared to saliva 
(Reynolds et al. 1998). Additionally investigating potential effects on 
serum/plasma levels could have allowed for stronger conclusions to be made 
about the effectiveness of consecutive daily sessions of tDCS on pain related 
biomarkers. 
With respect to experimental design, there are a number of factors that may 
have shaped the findings such as intervention timing, population type and 
outcome measure settings and timing. 
Firstly, it may be that the stimulation timing (i.e. once daily) was sub-optimal to 
elicit cumulative longer lasting effects on the sensory domain in a healthy 
population.  Indeed, the results of a recent systematic review suggested a 
lack of effect for current multiple dose tDCS strategies (e.g. once daily) on 
pain related outcome measures in a chronic pain population (O'Connell et al. 
2014).  
One alternative approach may be to deliver successive tDCS using shorter 
intervals (i.e. in the order of minutes) (Goldsworthy, Pitcher & Ridding 2014). 
In support of this approach, Monte-Silva et al. (2013) demonstrated that 
continuous application of 1mA motor cortex tDCS for 26 minutes resulted in 
motor pathway excitability changes that were shorter in duration when 
compared to spaced stimulation of the same total duration (i.e. 2x13 min of 
tDCS with 3 or 20 min interval) in a healthy population. In contrast, spaced 
stimulation of the same total duration using inter-tDCS intervals of hours 
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abolished plasticity induction. Similarly, research has demonstrated that with-
in session repeated tDCS (i.e. two or three applications of 10 minute tDCS 
with an interval of 25 minutes) was preferable for modifying motor pathway 
excitability and motor behavior (e.g. Purdue pegboard test) in a healthy 
population compared to a single application of 10 minute tDCS (Bastani, 
Jaberzadeh 2014). Further research into the effect of tDCS timing on 
psychophysical, subjective and objective measures is therefore warranted.  
Secondly, using healthy, pain free individuals to study pain mechanisms 
allowed for enhanced experimental control (i.e. related to stimulus intensity, 
frequency, localisation and duration) compared to clinical pain studies (Staahl, 
Drewes 2004). However, the short lasting stimuli used in this study does not 
reproduce actual clinical pain (Staahl, Drewes 2004). Consequently, the 
negative findings from this study may therefore not translate to a persistent 
pain population.  
As well, there was an attempt made to examine the effects of tDCS on 
substance P. However, the concentration results were hardly ever above the 
lower limit of detection. As significantly higher levels of salivary substance P 
have been found in chronic pain patients compared to healthy controls, it 
could be suggested that future related studies should focus on clinical chronic 
pain populations to evaluate the potential effects of consecutive daily sessions 
of tDCS on objective pain related outcome measures (Jang et al. 2011). 
Thirdly, another reason for the findings may be due to outcome measure 
settings and timings. Firstly, different variable settings were generally not 
used for each examined modality. For example, psychophysical thresholds in 
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Study 2 were only assessed on the body side contralateral to tDCS. However, 
change in a psychophysical threshold (i.e. innocuous cold sensitivity) on the 
body side ipsilateral to tDCS has previously been reported (Bachmann et al. 
2010). Furthermore, CPT was only assessed at the one temperature. 
Interestingly, Hamner et al. (2014) recently demonstrated significant tDCS 
induced reductions in CPT subjective ratings compared to sham when 
assessing CPT at a water temperature of 14 degrees and not 0 degrees. 
Hence, it could be suggested that future related studies that investigate the 
effects of consecutive daily tDCS on pain perception use different variable 
settings for each examined modality. This could possibly enable stronger 
conclusions to be made about the effectiveness of consecutive daily tDCS on 
experimental pain.  
With respect to outcome measure timing, the participant performed several 
psychophysical measurements with the same standardised procedure. 
However, the repeated sessions design can be susceptible to test-retest bias 
(e.g. retest performances influenced by previous sessions). Test-retest bias 
with psychophysical measures has previously been reported (Teepker et al. 
2010). In Study 1, it can be seen that for both active and sham tDCS groups 
that there was a steady reduction in 30Hz VDT for both sides over time. 
These findings could indicate that a learning or training effect may have been 
present for 30Hz VDT. Factoring session-to-session effects into the analyses 
would have required repeated psychophysical tests before start of the trial. 
This would have required more resources (i.e. project finances, participant 
time) to do so. Nonetheless, future related studies should factor session-to-
session effects to minimise the possibility of test-retest bias. 
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Moreover, we did not investigate the long term effects of consecutive daily 
sessions of tDCS induced effects. It is therefore not known if tDCS may have 
induced a long-term effect (Lang et al. 2007). Future related studies therefore 
should incorporate measures that can investigate potential long term tDCS 
induced effects. 
With respect to the correlations, the thesis demonstrated statistically 
significant correlations between psychophysical thresholds, between 
subjective assessments and between psychophysical thresholds and 
subjective assessments in a healthy population. 
There are a number of potential finding implications. To begin with, the results 
may provide further evidence of the clinical utility of different types of pain 
assessments. However, the weak to moderate correlations also suggest that 
different types of body pain stimuli assessments should be used to 
appropriately evaluate the level of an individual’s pain sensitivity. Likewise, 
caution must be applied in the interpretation of an individual’s pain sensitivity 
based off a single body pain stimuli assessment (Bhalang et al. 2005).  It can 
also be suggested that future studies investigate whether the level of an 
individual’s pain sensitivity assessed using a number of different body pain 
stimuli can indicate persistent pain condition development (Bhalang et al. 
2005). 
 
4.2 Concluding remarks 
Advancements in neuroscience methods have subsequently led to the use of 
non-invasive brain stimulation techniques in research. The challenge that is 
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consequently posed is can these techniques effectively harness the power of 
neuroplasticity for distinct and meaningful purposes, such as to further 
improve human body function or even treat certain disorders? 
This thesis attempts to make a contribution to addressing this research 
problem. It was hypothesised that the increasing stimulation frequency (i.e. 
using repeated daily tDCS) would enhance the consistency/efficacy of tDCS 
induced changes to somatosensory and pain perception in a healthy 
population. In contrast to this hypothesis, this was the first study to 
demonstrate that a once daily multiple dose strategy was sub-optimal to 
produce consistent and stronger anodal tDCS induced changes to 
somatosensory and pain perception in a healthy population. These findings 
may therefore help direct future research to develop more appropriate dose 
strategies that may eventually lead to therapeutic use of tDCS in the 
treatment of nervous system disorders such as in pain and stroke conditions.  
In addition, the research has provided further evidence that significant 
correlations exist between psychophysical thresholds, between subjective 
assessments and between psychophysical thresholds and subjective 
assessments in a healthy population. With further research, these findings 
may help lead to more appropriate evaluations of pain sensitivity in clinical 
populations.  
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Appendices 
Appendix 1 Study 1 explanatory statement  
 
Explanatory Statement 
Bond University Human Research Ethics Committee Protocol Number: 1439 
Study title: Modulation of somato-sensory cortex function with non-invasive brain stimulation. 
Investigators: 
Supervisor:   Associate Professor Peter Johnson 
PhD Student:  Brookes Folmli 
Research Aims 
Transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) 
are both non-invasive techniques capable of activating elements of the brain without causing 
pain. Recent research has provided evidence for the ability of both TMS and tDCS in inducing 
short term changes to certain regions within the human brain, which outlast the stimulation 
period. Effectively utilising non-invasive brain stimulation to temporally alter brain function 
could therefore improve our understanding of the human sensory system. 
Although research has further shown both TMS and tDCS to have effects on behavioural 
aspects of sensory function in healthy populations, more research is overtly required to 
advance our understanding of the potential effects on these measures with various repetitive 
TMS (rTMS) and tDCS based stimulating paradigms and protocols. In particular, no research 
has yet compared the effects of separate repeated session protocols of either TMS or tDCS 
on behavioural features of sensory processing.   
Vibration detection thresholds represent an objective method of measuring human sensory 
function in research procedures. It could therefore be hypothesized that the use of both 
protocol types would effectively modulate vibration detection thresholds. Consequently, the 
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aim of the current research project is to investigate the potential of different non-invasive 
brain stimulation protocols, namely TMS and tDCS, in changing specific measurable 
behavioural aspects of sensory function. At the same time, evaluating differences between 
the two protocols. Equipped with this knowledge, better directed clinical and pharmacological 
investigations related to the area could potentially be produced 
Procedures 
You will first be asked to read through the list of risks with the use of both TMS and tDCS 
(please see “List of risks with the use of TMS & tDCS” on page 5). You will then be asked to 
answer the pre-study questionnaire. If eligible, you will be subsequently allocated randomly to 
either a TMS or tDCS protocol group. 
During the first, third and final stimulation sessions only, vibration detection thresholds will be 
performed. An initial examination of vibration detection thresholds will be conducted. 
Vibrations will be delivered specifically to the skin surface of two different upper limb locations 
(i.e. finger on both sides) at two different frequencies via a mechanical vibrator. Vibration 
detection thresholds will involve placing your finger on the vibrator’s probe tip, which will be 
protruding through a hole in a perspex plate encasing it. Throughout the experiment, a series 
of different vibration amplitudes will be delivered to the skin surface, for which you will be 
asked to state whether or not you can detect the stimulus. For each site and frequency, the 
mean of 10 detection thresholds will be calculated.  
If you are in the TMS group, your level of motor cortex excitability will be measured first (i.e. 
prior to the pre repetitive stimulation vibration measurement). For this, self-adhesive surface 
electromyography (EMG) electrodes will be attached to your hand muscles to record the 
bioelectrical activity of these muscles in response to TMS. In order to evoke a muscle activity, 
stimulation of the motor cortex will be performed using a circular shaped coil. Your active 
motor threshold will be established, which is the lowest intensity required to consistently 
produce muscle activity in the contra-lateral hand to cortical stimulation during slight 
contraction of the hand muscles. Your active threshold will determine whether you are 
allowed to continue in the TMS group. If you are not allowed to continue in the TMS group, 
you will be placed in the tDCS group. If allowed to continue, the site of stimulation will then be 
located. Subsequent to the pre repetitive stimulation vibration measurement, rTMS will be 
applied at an intensity 20 % below that of your active threshold.  
If you are not in the TMS group, tDCS will instead then be delivered at a current intensity of 
1mA over the site of stimulation. For both groups, the vibration detection threshold will then 
be measured again post-stimulation to be compared with the before stimulation 
measurements. This session format will be repeated again on your third and final sessions. 
Sessions 2 and 4 will involve stimulation only. The experiment will therefore require you to 
participate for ~7hrs over five separate sessions on 5 consecutive days. Your time 
commitment will be compensated, i.e. 2x lunch vouchers ($40/ voucher) or $100. 
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Risks and Discomfort 
Currently, there are some known and potential risks associated with the use of both TMS and 
tDCS (please see “List of risks with the use of TMS & tDCS” on page 5). One possible 
adverse effect associated with TMS is the rare induction of a seizure. Research that has used 
the type of TMS protocol that will be applied in this study (i.e. 67 studies - number of 
participants totaled 1040 persons) has so far only reported one case of an induced seizure. In 
line with these findings, the risk for seizure induction is therefore considered very low. During 
or after stimulation muscle tension, headache or neck pain may arise due to activation of 
scalp and neck muscles, but these respond promptly to common analgesics. In sensitive 
subjects, a tingling sensation and twitch of facial muscles may also be felt during the 
application of TMS. The only absolute contra-indication to TMS is the presence of metallic 
hardware that is in close contact with the coil. Therefore, persons with metal implants will not 
be invited to participate. All procedures performed with TMS will strictly adhere to the 
measured safety guidelines.  
A direct current stimulator is operated by a common household battery and during stimulation 
there is hardly a sensation felt over the area of contact. Occasionally, headache, dizziness, 
nausea, fatigue, visual sensation, skin irritation and a tingling sensation under the area of the 
electrodes are reported as side effects. tDCS will also be performed with procedures similar 
to those which have been previously considered safe in humans. The PhD student will also 
go through the full list of risks associated with TMS and tDCS with you during your initial 
consultation before you give your consent. 
Confidentiality 
Confidentiality of your records will be adhered to. Your results will be securely stored on 
computer files, for which only the above researchers will have access to. All data 
corresponding to your results will be number coded so you will not be identified in any future 
reports or publications. 
Volunteer Participation 
You are free to withdraw from the conducted experiment at any stage of the research. 
Debriefing 
If you would like to be informed of the aggregate research finding, please contact the student 
investigator. A summary of the findings and how this has contributed to scientific knowledge 
will be emailed to those wanting this information. 
Counseling Services 
In addition to research enquires, if you require counselling over any experiences throughout 
the experiment please call:  
Lifeline Australia: 131 114; Bond University Counselling Office: 55 954 002 
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Research Ethics  
If you have any concerns in regards to the conduct or nature of this research (RO1439), 
please do not hesitate to contact the Bond University Research Ethics Committee at the 
following address: 
 
Senior Research Ethics Officer  
Complaints  
Bond University Human Research Ethics Committee  
Bond University  
Gold Coast, 4229  
Telephone: (07) 5595 4194 Fax (07) 5595 1120 Email: buhrec@bond.edu.au  
 
Research Inquires 
If you have any queries or would like to be informed of the aggregate research finding, please 
contact:  
Student Investigator: Mr. Brookes Folmli  
Signature: …………………………. 
Mobile: 0432 102 778 
 
Investigator: Associate Professor Peter Johnson 
Signature: ………………………… 
Telephone: 5595 4048 
Address:  School of Health Sciences & Medicine, Bond University 4229 
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List of risks with the use of TMS & tDCS  
Known adverse effects with TMS:  
 
1. Seizures: Single pulse TMS has resulted in seizures in patients, but not in normal subjects, 
whereas repetitive TMS has resulted in seizures in both patients and normal subjects. 16 
cases of TMS induced seizures have been reported. Considering the large number of 
experiments conducted using TMS, the risk of inducing seizures is very low.  
 
2. Heating of the brain: Heating of the brain is unlikely to cause injurious effects. The 
theoretical power exposed to during TMS is a few milliwatts at 1 Hz; while the brain's 
metabolic power (13 W). 
 
3. Heating sensation of the scalp: TMS can induce sensations of heat on the scalp due to coil 
heating; however, there is a monitor on the machine, which alerts when temperatures 
approach forty degrees Celsius. 
 
4. Syncope (fainting): Syncope can occur as an epiphenomenon (i.e. not related to direct 
brain effects). A syncope management plan has been implemented. 
 
5. Headaches and Local Pain: During TMS, induction of muscle tension headache or neck 
pain may arise possibly due to activation of scalp and neck muscles, which respond promptly 
to an aspirin, acetaminophen (Tylenol ®) or other common analgesics.  
 
6. Subjects may also experience nausea, and twitching of the face.  
 
Potential complications of TMS: 
 
1. Cognition: Repetitive TMS may result in memory problems and other cognitive deficits. 
These effects are very rare, mild, and very transient. Several safety studies with rTMS have 
revealed no adverse long-term effects or sustained changes in cognition. Most TMS studies 
have not seen any effects of rTMS on mental abilities, and some have actually improved 
cognitive function. 
       
2. Kindling: The process of repetitive sub-convulsive shocks leading to a subsequent epileptic 
event is highly unlikely. This is due to the fact kindling requires frequencies of at least 60Hz, 
and a pulse duration of 1ms longer than that seen in TMS. 
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3. Exposure to Magnetic fields: As TMS magnetic fields are only 2 Tesla and rapidly 
decaying; this should not have adverse effects.  
 
4. Endocrine function: There have been several reports of changes in hormone levels, in 
particular changes to pro-lactin levels, thyroid-stimulating hormone. However, there has been 
no evidence for clinically relevant changes in hormone functions. 
 
5. There have also been several reports of TMS induced changes to immune function, 
neurotransmitter levels & autonomic function. However, no deleterious effects have been 
reported. 
 
Known adverse effects with tDCS:  
 
Headaches and local pain, dizziness, nausea, fatigue, skin irritation and a tingling, itching or 
mild burning sensation under the area of the electrodes have all been reported as side effects 
with the use of tDCS. A visual sensation, associated with switching ‘on’ and ‘off’ the 
stimulation has also been reported.  
 
Potential complications with tDCS:  
1. Electrochemically produced toxic brain products and metallic electrode dissolution 
products at the electrode-tissue interface: In tDCS, there is no direct contact between 
the electrodes and brain tissue. As well, the metallic electrode will be placed between 
two sponges, which should act to buffer the skin from electrochemical changes. 
 
2. Current-induced neuronal hyper-excitability and brain tissue heating: This specifically 
refers to effects induced by high frequency supra-threshold stimulation lasting for 
hours. Considering tDCS induces only moderate changes in cortical excitability, a 
damaging effect by neuronal hyper-activity seems improbable.  
 
 
 
 
  147 
Appendix 2 Study 1 pre-study 
questionnaire 
 
Pre-study questionnaire  
Please read the following items carefully and put a tick (✓) on the answer that best 
corresponds to your current situation. Please be advised that the responses you provide for 
this questionnaire will be kept strictly confidential and will be used only for the purposes of 
this research. Therefore, please answer as honestly as you can. If you have questions please 
do not hesitate to ask the investigators: Brookes Folmli (bfolmli@student.bond.edu.au) and 
Peter Johnson (pejohnso@bond.edu.au). 
1. Subject Details 
Name, SID  
Mobile number  
Emergency contact (number, 
name + relationship to subject)  
Age  
Date form filled  
Gender Male                    Female  
Handedness Right                            Left        
How did you find out about this 
research?  
2. Eligibility 
If you tick yes to any of the following questions in Part A, you will be excluded from 
the study: 
PART A: 
Do you have any metallic or magnetic pieces inside your brain/skull 
(except titanium) (e.g. splinters, clips)? Yes       No  
Do you have any implanted metal devices that you are aware of (e.g. 
cochlear, pacemaker, medication pumps, and neuro-stimulators such 
as deep brain stimulators)? Yes       No  
Do you have epilepsy or have ever experienced a convulsion or 
seizure?  Yes       No  
Do you have any first degree relatives with epilepsy? Yes       No  
Do you have any hearing problems or tinnitus (ringing in the ears)? Yes       No  
Are you someone who consumes heavy amounts of alcohol (e.g. +4 
standard drinks/day very regularly)? Yes       No  
Have you had any recent or severe heart disease? Yes       No  
Are you pregnant or is there any chance you might be?  Yes       No  
If you tick yes to any of the following questions in Part B,  an individual evaluation of 
your eligibility will be determined: 
PART B: 
  148 
Do you have or have ever experienced any focal or generalized 
neurological condition (e.g. tumour, stroke, encephalitis, severe 
head trauma, fainting spells)? – if other please specify in the 
available space underneath the boxes 
Yes       No  
 
 
Have you had any recent upper limb injuries? If yes please 
specify the type of injury in the available space 
Yes       No  
 
 
 
Have you ever been involved in a transcranial magnetic 
stimulation (TMS) and/or transcranial direct current stimulation 
(tDCS) study? If yes please specify the type of study in the 
available space.  
Yes       No  
 
 
 
Do you suffer from any skin condition (e.g. eczema)? 
Yes       No  
 
 
Please list any medication you are taking (or have recently withdrawn from) in the space 
below: 
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Appendix 3 Study 1 informed consent 
 
Statement of Consent 
Bond University Human Research Ethics Committee Protocol Number: 1439 
I agree to participate in the above Bond University study. I fully understand that my 
participation in the study is voluntary only, and can withdraw from the experiment at any time. 
I also recognise that I will not be identified in any reports on the project, nor to any other 
party. I have also read the attached explanatory sheet and am fully aware of all associated 
aims, procedures and risks involved with the investigation. Therefore, I am willing to:  
x Provide my age and handedness to be used in future reports and publications in a non-
identified form,  
x provide a series of vibration detection threshold measurements 6 times over 3 separate 
days,  
x allow the researchers to perform either transcranial magnetic stimulation (TMS) OR 
transcranial direct current stimulation (tDCS) on me, 
x have my results of all assessment items be used in future reports and publications in a 
non-identified form. 
Name (please print):        .........................................................................................  
Signature:                             ......................................................................................... 
Date:                                     ……………………………………………………………….. 
Independent witness 
I believe that                        …………………………………………………………………                       
fully understands the above project and gives her/his consent voluntarily. 
Name (please print):        .........................................................................................  
Signature:                             ......................................................................................... 
Date:                                    ………………………………………………………………… 
Address: School of Health Sciences & Medicine, Bond University 4229 
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Appendix 4 Study 2 explanatory statement 
 
 
Explanatory Statement 
Bond University Human Research Ethics Committee Protocol Number: RO1693 
Study title: Modulation of experimental pain with non-invasive brain stimulation. 
Investigators: 
Supervisor:  Assistant Professor Allan Abbott, Associate Professor Peter Johnson 
& Professor Wayne Hing 
PhD Student:  Brookes Folmli 
Research aims and benefits 
Recent development of non-invasive brain stimulation techniques has provided important 
insight into human nervous system function. Transcranial direct current stimulation (tDCS) is 
one such technique, which involves delivering electrical current to the brain via surface 
electrodes. Further research, however, is required to evaluate the effects of consecutive daily 
application of tDCS on human sensory function. Consequently, the aim of the current 
research project is to investigate whether five consecutive daily sessions (1 session / 
treatment day) of tDCS can improve sensory function in a healthy human population. The 
results of this study will lead to better 1) understanding of human sensory function modulation 
and 2) directed clinical and pharmacological investigations related to the area. 
Procedures 
You will first be asked to read through the explanatory statement. You will then be asked to 
answer the ‘pre-study questionnaire.’ If eligible, you will be subsequently allocated randomly 
to either the ‘real’ or ‘placebo’ tDCS treatment group. 
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Prior to the stimulation intervention, an assessment of your sensitivity to electrical, thermal 
and mechanical induced pain (i.e. experimentally induced pain) stimuli will be performed. For 
this, a series of pressure, thermal and electrical stimuli will be delivered to the skin surface of 
your dominant hand. You will be asked to state when you can first ‘detect’ the electrical 
stimulus. The mean of 3 ‘detection’ thresholds will be calculated. The electrical, thermal and 
pressure stimuli will be delivered until you can first confidently perceive the stimulus as being 
‘painful.’ For each type of stimulus, the mean of 3 ‘pain’ thresholds will be calculated. 
Furthermore, the thermal stimuli will continue to be delivered until you can no longer tolerate 
the stimuli. As well, you will be asked to indicate the intensity of the pain when you first 
perceived the stimulus as being ‘painful’ and ‘no longer tolerable’ on a visual analogue scale. 
Once the experimentally induced pain measures have been performed, tDCS will then be 
delivered over the site of stimulation via two scalp electrodes on 5 consecutive days (1 
session / treatment day).  
The ‘experimentally induced pain’ assessments will be performed again after the first and final 
stimulation intervention sessions. As well, you will be asked to indicate 1) YES or NO to the 
question ‘‘Do you feel that you have just received the ‘real’ stimulation intervention?’’ and 2) 
the level of confidence in your answer on a numeric rating scale. You will also be asked to 
complete an adverse effects questionnaire and questions related to general pain sensitivity 
during your final session. Additionally you will be asked to provide a saliva sample before and 
after the stimulation intervention. This will enable the research to determine if tDCS induced 
effects on sensory function are associated with changes to the saliva level of a particular 
biological substance, which is known to impact the nervous system. Sessions 2-4 will involve 
brain stimulation only. The experiment will therefore requires you to participate for ~5.5hrs 
spread over 5 separate sessions (1 session / day). Your time commitment will be 
compensated, i.e. $100.  
Research Site 
The study will be performed at Bond University, Robina. 
Risks and Discomfort 
Research has reported that 18% of subjects found the stimulation procedure mildly 
unpleasant. The following mild discomforts were reported during stimulation: tingling (70%), 
itching (30%), non-harmful burning sensation (22%) and local pain (16%) under the area of 
the electrodes. Some subjects reported mild and short-term headache (4%), nausea (3%), 
skin irritation (i.e. mild redness), and a visual sensation (i.e. flash of light) (9%) when turning 
the stimulation on and off. Potential discomforts with experimental pain include short-term 
local pain and skin irritation during testing. 
To minimize this, the stimulation protocols will be adhering to safety guidelines. These 
potential risks will be lowered further through the use of thorough subject exclusion criteria. 
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The PhD student will also go through the full list of risks associated with tDCS and 
experimental pain with you during your initial consultation before you give your consent. 
 
Confidentiality 
Confidentiality of your records will be adhered to. Your results will be securely stored on 
computer files, for which only the above researchers will have access to. All data 
corresponding to your results will be number coded so you will not be identified in any future 
reports or publications. 
Volunteer Participation 
You are free to withdraw from the conducted experiment at any stage of the research. 
Debriefing 
If you would like to be informed of the aggregate research finding, please contact the student 
investigator. A summary of the findings and how this has contributed to scientific knowledge 
will be emailed to those wanting this information. 
Counselling Services 
In addition to research enquires, if you require counselling over any experiences throughout 
the experiment please call:  
Lifeline Australia: 131 114 
Bond University Counselling Office: 55 954 002 
Research Ethics  
If you have any concerns in regards to the conduct or nature of this research (RO1693), 
please do not hesitate to contact the Bond University Research Ethics Committee at the 
following address: 
 
Senior Research Ethics Officer  
Complaints  
Bond University Human Research Ethics Committee  
Bond University  
Gold Coast, 4229  
Telephone: (07) 5595 4194 Fax (07) 5595 1120 Email: buhrec@bond.edu.au  
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Research Inquires 
If you have any queries or would like to be informed of the aggregate research finding, please 
contact:  
Student Investigator: Mr. Brookes Folmli  
Signature: …………………………. 
Mobile: 0432 102 778 
 
Investigator: Assistant Professor Allan Abbott 
Signature: …………………………… 
Telephone: 5595 4449 
Address:  School of Health Sciences & Medicine, Bond University 4229 
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Timeline of events 
 
 
 
           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
You will come to Bond University for: 
1. Completion of ‘pre-study 
questionnaire.’ 
2. ‘Experimentally induced pain’ 
assessments. 
3. Provide saliva samples. 
4. Numeric rating scale 
measurements. 
5. tDCS. 
6. Completion of adverse effects 
questionnaire. 
Session 1 duration: ~2hrs 
Session 5 duration: ~1.5hrs 
Treatment over 5 days 
You will come to Bond 
University for tDCS. 
Sessions 2, 3 + 4 duration: 
~45min 
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Appendix 5 Study 2 pre-study questionnaire 
Pre-study questionnaire  
Please read the following items carefully and put a tick (✓) on the answer that best 
corresponds to your current situation. Please be advised that the responses you provide for 
this questionnaire will be kept strictly confidential and will be used only for the purposes of 
this research. Therefore, please answer as honestly as you can. If you have questions please 
do not hesitate to ask the investigators: Brookes Folmli (bfolmli@student.bond.edu.au) and 
Allan Abbott (aabbott@bond.edu.au). 
1. Subject Details 
Name  
Mobile number  
Emergency contact (number, 
name + relationship to subject)  
Age  
Date form filled  
Gender Male                    Female  
Handedness Right                            Left        
2. Eligibility 
If you tick yes to any of the following questions in Part A, you will be excluded from 
the study: 
PART A: 
Do you have any metallic or magnetic pieces inside your 
brain/skull (except titanium) (e.g. splinters, clips)? Yes       No  
Do you have any implanted metal devices that you are aware of 
(e.g. cochlear, pacemaker, medication pumps, and neuro-
stimulators such as deep brain stimulators)? Yes       No  
Do you have epilepsy or have ever experienced a convulsion or 
seizure?  Yes       No  
Are you someone who consumes heavy amounts of alcohol (e.g. 
+4 standard drinks/day) very regularly? Yes       No  
Have you had any recent or severe heart disease? Yes       No  
Are you pregnant or is there any chance you might be?  Yes       No  
If you tick yes to any of the following questions in Part B,  an individual evaluation of 
your eligibility will be determined: 
PART B: 
Do you have or have ever experienced any focal or generalized 
neurological condition (e.g. tumour, stroke, encephalitis, severe 
head trauma, fainting spells)? – if other please specify in the 
available space underneath the boxes 
 
Yes       No  
 
  156 
 
Please list any medication you are taking (or have recently withdrawn from) in the space 
below: 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Have you ever been involved in a transcranial direct current 
stimulation (tDCS) study?  
Yes       No  
 
 
 
Do you currently have hair extensions and/ or very thick and 
course hair? Yes       No  
 
Do you have any skin condition (e.g. eczema), which is located on 
the scalp and/or forehead? 
Yes       No  
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Appendix 6 Study 2 informed 
consent 
 
 
Statement of Consent 
Bond University Human Research Ethics Committee Protocol Number: RO1693 
I agree to participate in the above Bond University study. I fully understand that my 
participation in the study is voluntary only, and can withdraw from the experiment at any time. 
I also recognise that I will not be identified in any reports on the project, nor to any other 
party. I have also read the attached explanatory sheet and am fully aware of all associated 
aims, procedures and risks involved with the investigation. Therefore, I am willing to:  
x Provide my age and handedness to be used in future reports and publications in a non-
identified form,  
x Provide a series of ‘experimentally induced pain’ measurements,  
x Provide saliva samples 
x Complete a series of numeric rating scales, 
x Allow the researchers to perform transcranial direct current stimulation (tDCS) on me, 
x Complete an adverse effects questionnaire 
x Have my results of all assessment items be used in future reports and publications in a 
non-identified form. 
Name (please print):        .........................................................................................  
Signature:                             ......................................................................................... 
Date:                                     ……………………………………………………………….. 
 
I (full name of parent/ guardian and relationship to child):    
………………………………………………………………………………………………………….. 
understand the aims, procedures and risks involved with the investigation and 
give permission for (full name of child):  …………………………………………………………… 
to participate in the RO1693 research.   
Signature:                               ................................................................................... 
Date:                                      ………………………………………………………….. 
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Appendix 7 Study 2 pain visual analogue scales 
 
 
 
 
 
  
 
 
Place a vertical mark on the lines above to indicate the intensity of pain when you first 
perceived the stimulus as being ‘painful.’  
 
 
 
 
 
 
 
 
 
Place a vertical mark on the lines above to indicate the intensity of pain when you could no 
longer tolerate the stimuli.  
 
 
 
 
0 10 
No pain Pain as bad as you 
can imagine 
No pain Pain as bad as you 
can imagine 
0 10  
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Appendix 8 Study 2 brief sensation test protocol 
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Appendix 9 Study 2 participant blinding visual 
analogue scales 
 
 
Visual Analogue Scale (participant blinding) 
Do you feel that you have just received the ‘real’ stimulation intervention? 
Yes   
No   
 
 
 
 
 
 
Not confident at all       completely 
confident 
Place a vertical mark on the line above to indicate the level of confidence you have in your 
answer.   
 
 
 
0 
10 
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Appendix 10 Study 2 scalp stimulation adverse 
effects questionnaire 
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Appendix 11 Study 2 self-report general pain 
sensitivity questionnaire 
 
 
 
 
 
 
